Introducton {#s1}
===========

Nutrient-depleted cells can only persist long-term by initiating a two-pronged survival response: they need to be able to recycle cytoplasmic components and they need a source of energy available from within the cell. The first is achieved through self-digestion involving bulk autophagy pathways ([@bib17]; [@bib58]), and the second requires a shift to metabolizing lipids for ATP production given the unavailability of glucose ([@bib20]; [@bib59]). Unless both responses are triggered, cell and organismal survival are jeopardized.

How bulk autophagy and lipid consumption pathways are coordinated to permit long-term survival in starved cells represents a fundamental and challenging question. Its answer is particularly relevant to aging research as caloric restriction and enhanced lifespan in various organisms are related ([@bib9]). But not all caloric restriction programs have the same beneficial effects on organismal health and survival ([@bib18]; [@bib57]). For example, yeast cells starved by different nutrient regimes either die quickly or live long-term ([@bib14]); mice strains with differing sensitivities to different nutrients show variable responses to caloric restriction ([@bib30]); and non-human primates exhibit short or long lifespans on different starvation diets ([@bib10]). These results raise the possibility that cells mount distinct survival responses depending on the starvation condition, with only some regimens activating both lipid catabolism and autophagy, which are necessary for long-term survival.

In this study, we use imaging and functional analysis approaches to investigate the conditions, and signaling and organellar systems, that trigger bulk autophagy and lipid consumption pathways to permit long-term survival under starvation. Using the budding yeast *Saccharomyces cerevisiae* as our model system, we demonstrate that to initiate and sustain bulk autophagy and lipid droplet (LD) breakdown pathways together, starved cells need to sense an acute reduction in glucose levels. Cells undergoing gradual glucose reduction or mere amino acid starvation, by contrast, only induce bulk autophagy without initiating LD consumption, and do not survive long-term. We further show that LD consumption in cells undergoing acute glucose starvation occurs by the process of micro-autophagy of LDs (i.e. µ-lipophagy), which is dependent on AMPK activation and core autophagic machinery. Atg14p plays a particularly important role in this process. It shifts its distribution from ER exit sites (ERES) to liquid-ordered membrane domains on the vacuolar surface in response to AMPK activation where, together with Atg6p, it facilitates vacuole docking and internalization of LDs. Cells that cannot activate AMPK or that lack Atg14p or Atg6p do not deliver LDs into the vacuole for degradation and fail to thrive under acute glucose starvation. These findings highlight the importance of µ-lipophagy and its regulation for understanding the cellular mechanisms underlying lifespan extension under calorie restriction and show a fundamental plasticity in the regulation and function of core autophagy components in response to different metabolic or stress conditions.

Results {#s2}
=======

Cellular responses associated with prolonged lifespan under acute glucose restriction {#s2-1}
-------------------------------------------------------------------------------------

Prior work in budding yeast has shown that different regimens of depleting glucose during starvation lead to dramatically different cellular lifespans ([@bib5]; [@bib45]). In particular, cells growing in synthetic minimal (SD) media (containing a restricted set of amino acids) with 2% glucose that are shifted into 0.4% glucose with no nutrient replenishment (i.e. acute glucose restriction, Acute GR) survive significantly longer than those placed in similar media containing 2% glucose (i.e. gradual glucose restriction, Gradual GR), even though a majority of nutrients become completely depleted within 1 day under both conditions. This surprising effect is shown in [Figure 1A](#fig1){ref-type="fig"}, with \~99.9% of cells starved by gradual GR dying within 9 days and nearly all cells starved by acute GR still alive after 25 days ([Figure 1A](#fig1){ref-type="fig"}). Thus, when starved of all nutrients, yeast cells survive differentially depending on whether they have sensed glucose being drained quickly or slowly out of the media.10.7554/eLife.21690.002Figure 1.Starvation by acute GR increases cell survival and induces vacuolar LD delivery.(**A**) Long-term survival of cells undergoing gradual or acute GR was measured as described in the Materials and methods. Cell survival is plotted as the log of a percentage viable cell number at day 1 (which was set at 100%). Three biologically independent experiments are shown together. (**B**) Cell respiration was determined during a cell survival experiment described in the Materials and methods. O~2~ consumption rate is plotted as a percentage of that seen in cells under gradual GR at day 1 (which was set at 100%). (**C**) Representative SXT orthoslice image of a yeast cell under non-starvation is shown. (**D**) Representative SXT orthoslice images of yeast cells under day 1.5 (D1.5) of gradual or acute GR are shown. Arrowheads indicate LDs inside the vacuole. Scale bar represents 0.5 μm. Lower panels show full 3D SXT images (LD: green; nucleus: purple; vacuole: pale yellow; mitochondria: gold). (**E**) Percentage of cells having only cytoplasmic LDs (Cyt LD) or having both Cyt LD and vacuole associated LDs (Vac LD) are shown. Data were analyzed from full 3D tomograms of the SXT images. Approximately 50 cells per each condition were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.002](10.7554/eLife.21690.002)10.7554/eLife.21690.003Figure 1---figure supplement 1.Starvation by acute GR enhances cellular oxidative stress resistance and induces mitochondrial tubulation.(**A**) Cells grown under gradual or acute GR were subject to oxidative stress (2.5 mM H~2~O~2~ or 30 μM menadione). Cell viability is plotted as a log of viable cell number at the indicated days. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions. (**B**) WT cells harboring mitochondrial matrix targeting GFP (mtGFP) grown under acute or gradual GR conditions are shown at day 1 (D1) and day 4 (D4). Scale bar represents 5 μm. (**C**) Morphologies of mitochondria under no GR, acute GR or gradual GR from D1 to D5 were scored as 'Tubulated', 'Fragmented', 'None' or 'Dead' and represented as percentages. Approximately 150 cells per each condition were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.003](10.7554/eLife.21690.003)10.7554/eLife.21690.004Figure 1---figure supplement 2.LDs and vacuolar lipase Atg15p are necessary for cell survival during starvation.(**A**) Representative LD (Nile red positive structure) images from WT, LD-deficient (LDΔ), steryl ester deficient (SEΔ), and triacylglycerol-deficient (TAGΔ) cells under gradual GR for \~24 hr are shown. Genotype and LD phenotype of the aforementioned cells are summarized in the right panel. In the lower panel, cell survival of the aforementioned cells was determined as described in the Materials and methods. Representative colony images at the indicated days are shown. (**B**) Cell survival of WT, *tgl3Δ*, *tgl4Δ,* and *atg15Δ* cells under gradual GR was measured as described in the Materials and methods. Representative colony images at day 1 and day 5 are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.004](10.7554/eLife.21690.004)

To explore what metabolic features were associated with the increased survival of yeast cells undergoing rapid depletion of glucose from the media (i.e. Acute GR), we first examined changes in their cell respiration (i.e. oxygen consumption). Prior to glucose restriction, cells had very low oxygen consumption rates due to the cell's reliance on glycolysis ([@bib35]). By day 1 of GR, acutely-restricted cells had amplified their oxygen consumption rates to 2.2X that of gradually restricted cells ([Figure 1B](#fig1){ref-type="fig"}). Thereafter, acutely restricted cells maintained this higher respiratory rate, whereas gradually restricted cells exhibited a negligible oxygen consumption rate by day 3.

We also investigated the effect of oxidative stress on long-term cell viability under acute or gradual GR. Only cells undergoing acute GR remained viable after exposure to different oxidative stressors (i.e. hydrogen peroxide and menadione) ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), with their viability resembling that of cells undergoing acute GR without stressors. Examining mitochondria morphology next, we observed that cells undergoing acute GR for 3 days had highly fused and elaborate mitochondria, whereas those undergoing gradual GR had exceedingly fragmented mitochondria ([Figure 1---figure supplement 1B and C](#fig1s1){ref-type="fig"}). Cells undergoing acute GR thus appear to have greater respiratory rates, increased stress resistance, and more highly fused mitochondria than cells undergoing gradual GR.

Relationship between LDs and the vacuole under acute GR {#s2-2}
-------------------------------------------------------

A crucial way that cells alleviate metabolic demands during glucose deprivation is to form and consume LDs, whose fatty acid products fuel mitochondrial oxidative phosphorylation (OXPHOS) under starvation ([@bib44]; [@bib50]). In studying this response, we found that cells genetically modified so they could not form LDs died quickly under glucose starvation ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}; also see \[[@bib51]\]). Moreover, cells without vacuolar lipases had reduced survival rates under GR ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}; also see \[[@bib50]\]). These results suggested that metabolic reprogramming for long-term survival under glucose starvation requires the activities of LDs and the vacuole.

To visualize LDs and the vacuole under glucose starvation, we employed soft X-ray tomography (SXT). This technique gives a full 3D tomographic view of cryo-immobilized cells at 50 nm resolution, with no chemical fixation ([@bib29]). Organelles are distinguishable based on the extent they absorb X-rays, with carbon-rich organelles (such as LDs) absorbing more X-rays and generating higher contrast than fluid-filled organelles, such as the yeast vacuole ([@bib49]).

In non-starved cells imaged using SXT, LDs (appearing as black spherical structures) were exclusively localized in the cytoplasm, with none appearing within the vacuole ([Figure 1C](#fig1){ref-type="fig"}, Non-starvation). A similar cytoplasmic location was observed for LDs in cells undergoing gradual GR ([Figure 1D](#fig1){ref-type="fig"} and [Video 1](#media1){ref-type="other"}, Gradual GR). By contrast, in cells starved by acute GR, LDs were observed in both the cytoplasm and vacuole ([Figure 1D](#fig1){ref-type="fig"} and [Video 2](#media2){ref-type="other"}, Acute GR); those in the vacuole appeared to have been engulfed as whole droplets. Quantification of the images revealed that approximately 60% of cells starved by acute GR contained vacuole-localized LDs compared to only \~10% of cells starved by gradual GR and none of non-starved cells ([Figure 1E](#fig1){ref-type="fig"}). These results suggested that under acute GR cells quickly activate a cellular response pathway involving LD delivery into the vacuole, where LDs are digested to fuel mitochondrial OXPHOS.Video 1.A representative SXT movie of yeast cells under gradual GR.SXT images of cells grown under gradual GR for 1.5 days were processed and segmented to show individual organelle morphologies (LDs: green; nucleus: purple; vacuole: pale yellow; mitochondria: gold).**DOI:** [http://dx.doi.org/10.7554/eLife.21690.005](10.7554/eLife.21690.005)10.7554/eLife.21690.005Video 2.A representative SXT movie of yeast cells under acute GR.SXT images of cells grown under acute GR for 1.5 days were processed and segmented to show individual organelle morphologies (LDs: green; nucleus: purple; vacuole: pale yellow; mitochondria: gold).**DOI:** [http://dx.doi.org/10.7554/eLife.21690.006](10.7554/eLife.21690.006)10.7554/eLife.21690.006

Vacuole uptake of LDs under acute GR occurs by µ-lipophagy {#s2-3}
----------------------------------------------------------

LD delivery to and degradation in the vacuole could occur either by an autophagy -dependent or -independent pathway ([@bib50]; [@bib53]). Since autophagy requires core machinery, including Atg1p and Atg8p ([@bib32]; [@bib36]), we monitored the location and quantity of LDs using SXT in autophagy-deficient *atg1Δ* and *atg8Δ* cells under acute or gradual GR conditions. Virtually, no LDs were found inside the vacuole of *atg1Δ* or *atg8Δ* cells at 1.5 days of acute GR, in contrast to wild-type (WT) cells undergoing acute GR ([Figure 2A](#fig2){ref-type="fig"}, top panel, see quantification in [Figure 2B](#fig2){ref-type="fig"}). Instead, the droplets were primarily localized in the cytoplasm, similar to that seen under gradual GR conditions ([Figure 2A](#fig2){ref-type="fig"}, bottom panel). This indicated that LD accumulation within the vacuole during acute GR occurs by autophagy. During this process, LDs appeared to be directly engulfed by the vacuole by a micro-autophagy mechanism, as previously reported ([@bib50]; [@bib52]). Herein, we call this process µ-lipophagy.10.7554/eLife.21690.007Figure 2.Under acute GR, cytosolic LDs are engulfed by the vacuole and digested via μ-lipophagy.(**A**) Representative SXT orthoslice images of WT, *atg1Δ*, and *atg8Δ* cells undergoing acute or gradual GR for day 1.5 (D1.5) are shown. Black arrowheads point to LDs inside the vacuole. Scale bar represents 0.5 μm. (**B**) Percentage of cells having only cytoplasmic LDs (Cyt LD) or having both Cyt LD and vacuole associated LDs (Vac LD) are shown. Data were analyzed from full 3D tomograms of the SXT images in (**A**). Approximately 20 cells per each condition were analyzed. (**C**) LD volume analyzed from full 3D SXT images of WT and *atg1Δ* cells in (**A**) is shown as a percentage of that seen in cells undergoing gradual GR (which was set at 100%). Data are expressed as mean ± SD (*n* = 7 \~ 10). (**D**) WT and *atg1Δ* cells expressing Erg6-DsRed (LD marker) were grown under similar conditions in (**A**) and Erg6p degradation was measured by Western blot analysis. Quantification of Erg6p degradation is shown in the lower panel as ratio of free DsRed to total DsRed (free DsRed + Erg6-DsRed) signals. (**E**) Representative confocal images of cells in (**D**) are shown. White arrowheads point to vacuolar localized LD signals. Scale bar represents 5 μm. (**F**) WT and *atg1Δ* cells expressing GFP-Atg8 (autophagosome marker) were grown under similar conditions in (**A**) and Atg8p degradation was measured by Western blot analysis. Quantification of Atg8p degradation is shown in the lower panel as ratio of free GFP to total GFP (free GFP + GFP-Atg8) signals. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.007](10.7554/eLife.21690.007)

Several lines of evidence suggested that LD content delivered into the vacuole by µ-lipophagy was catabolized there for energy production. First, WT cells undergoing acute GR had \~50% less total LD volume relative to the cells undergoing gradual GR, with most LD volume in the vacuole; and, this reduction in total LD volume was absent in *atg1Δ* cells undergoing acute GR ([Figure 2C](#fig2){ref-type="fig"}). Second, Western blot analysis of cells expressing the LD marker Erg6-DsRed revealed that within 3 days of starvation, WT cells under acute GR produced high levels of free DsRed, indicative of LD turnover, whereas similarly starved *atg1Δ* cells did not ([Figure 2D](#fig2){ref-type="fig"}, Acute GR). Virtually, no free DsRed was released from cells undergoing gradual GR in WT or *atg1Δ* cells ([Figure 2D](#fig2){ref-type="fig"}, Gradual GR). Finally, confocal imaging of Erg6-DsRed-expressing cells showed DsRed signal dispersed inside the vacuole between day 1 and day 3 of acute GR ([Figure 2E](#fig2){ref-type="fig"}, see arrowheads), whereas DsRed signal was associated with cytoplasmic puncta in either *atg1Δ* cells or cells starved by gradual GR. Thus, the µ-lipophagy triggered by acute GR leads to LD turnover in these cells.

Examining overall autophagy rates using GFP release from GFP-Atg8 revealed that autophagic flux was maintained long-term under acute GR but not under gradual GR ([Figure 2F](#fig2){ref-type="fig"}). It is cells that sense acute GR, therefore, that can initiate and maintain both µ-lipophagy and bulk autophagy pathways for long-term survival under complete nutrient deprivation.

TOR pathway inhibition obstructs rather than boosts µ-lipophagy {#s2-4}
---------------------------------------------------------------

To begin dissecting the mechanism(s) that trigger and maintain µ-lipophagy seen under acute GR, we asked whether amino acid sensing could play a role. To address this possibility, we replaced SD media (which lacks a majority of amino acids) with synthetic complete (SC) media, which contains excess amino acids. No significant change in the management of autophagy and LDs under acute or gradual GR occurred by this media switch ([Figure 3A and B](#fig3){ref-type="fig"}). Total autophagic flux and µ-lipophagy remained higher under acute GR compared to gradual GR. This suggested amino acid depletion is not a major factor in triggering µ-lipophagy during acute GR.10.7554/eLife.21690.008Figure 3.Vacuolar LD consumption is dependent on AMPK and is not induced by rapamycin treatment.(**A**) WT cells expressing GFP-Atg8 were placed in synthetic complete (SC) media containing 2% glucose (Gradual GR) or 0.4% glucose (Acute GR). Autophagic flux assay was performed as described in [Figure 2F](#fig2){ref-type="fig"}. (**B**) LD flux assay as described in [Figure 2D](#fig2){ref-type="fig"} was performed under similar conditions as in (**A**). (**C**) Autophagic flux assay was performed with 50 nM rapamycin under similar conditions as described in (**A**). (**D**) LD flux assay was performed with 50 nM rapamycin under similar conditions as described in (**B**). (**E**) LD flux assay was performed in WT, *snf1Δ*, and *snf4Δ* cells as described in [Figure 2D](#fig2){ref-type="fig"}. (**F**) Representative confocal images of cells in (**E**) with both Erg6-DsRed and Vph1-GFP (vacuole membrane marker) are shown. White arrowhead points to LD signal localized within the vacuole. Scale bar represents 5 μm. (**G**) Representative SXT images of WT and *snf1Δ* cells undergoing acute GR for day 1.5 (D1.5) are shown. Black arrows and white arrows point to LDs and autophagic bodies, respectively. Scale bar represents 1 μm. (**H**) Quantification of autophagic flux in WT, *snf1Δ*, and *snf4Δ* cells is shown as described in [Figure 2F](#fig2){ref-type="fig"}. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.008](10.7554/eLife.21690.008)10.7554/eLife.21690.009Figure 3---figure supplement 1.Snf1p is required for vacuolar LD consumption, cellular energy metabolism, and long-term survival during acute GR.(**A**) SXT images of WT and *snf1Δ* cells grown under acute GR for day 1.5 (D1.5) were processed to show individual organelles (LDs: green; nucleus: purple; vacuole: pale yellow; mitochondria: gold). (**B**) Percentage of total LD volume per cell volume was measured from cells in (**A**). Data are expressed as mean ± SD (*n* = 7). (**C**) Autophagic flux assay was performed in WT, *snf1Δ,* and *snf4Δ* cells as described in [Figure 2F](#fig2){ref-type="fig"}. Representative blot images are shown. (**D**) ATP levels of WT and *snf1Δ* cells undergoing acute or gradual GR were measured as described in the Materials and methods. Cellular ATP levels at day 1 (**D1**) were set at 100% and presented as percentage at the indicated days. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions. (**E**) Cell viability of cells in (**A**) was determined and presented as described in [Figure 1A](#fig1){ref-type="fig"}. Three biologically independent experiments are shown together.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.009](10.7554/eLife.21690.009)

To further test this inference, we included rapamycin (which directly inhibits target of rapamycin (TOR), the major amino acid sensor in cells ([@bib1]; [@bib23]) in our experiments. We began by investigating gradual GR. Rapamycin treatment of cells undergoing gradual GR led to a transient increase in autophagic flux ([Figure 3C](#fig3){ref-type="fig"}, gradual GR). This was as expected given inactivated TOR's role in triggering autophagy. However, the autophagy could not be maintained and declined within 1 day. Notably, LD degradation (assessed using Erg6-DsRed) in rapamycin-treated cells under gradual GR remained low ([Figure 3D](#fig3){ref-type="fig"}, Gradual GR), similar to cells under gradual GR not treated with rapamycin (see Gradual GR in [Figure 3B](#fig3){ref-type="fig"}). This showed that TOR inactivation by rapamycin in cells undergoing gradual GR does not induce long-term autophagic flux or µ-lipophagy.

We next examined the effect of rapamycin treatment on cells undergoing acute GR. No substantial boost occurred in general autophagic flux ([Figure 3C](#fig3){ref-type="fig"}, Acute GR) compared to untreated cells undergoing acute GR (see [Figure 3A](#fig3){ref-type="fig"}, Acute GR). However, LD degradation was surprisingly decreased ([Figure 3D](#fig3){ref-type="fig"}, Acute GR) relative to untreated cells undergoing acute GR (see [Figure 3B](#fig3){ref-type="fig"}, Acute GR). This suggested that inactivation of the amino-acid-sensing TOR system during acute GR blocks µ-lipophagy rather than promotes it.

AMPK involvement in µ-lipophagy and cell survival under acute GR {#s2-5}
----------------------------------------------------------------

AMPK, the master energy sensor within cells, is activated by glucose depletion ([@bib9]). We tested its role in inducing µ-lipophagy in cells undergoing acute GR by examining starved cells lacking AMPK (i.e. *snf1Δ* or *snf4Δ* cells) ([@bib22]). The high levels of LD degradation (assessed by release of free DsRed from Erg6-DsRed) characteristic of acute GR in WT cells were not seen in *snf1Δ* or *snf4Δ* cells undergoing acute GR ([Figure 3E](#fig3){ref-type="fig"}, Acute GR), and instead resembled that of WT, *snf1Δ*, or *snf4Δ* cells when undergoing gradual GR ([Figure 3E](#fig3){ref-type="fig"}, Gradual GR). LD consumption seen under acute GR thus appears to require AMPK activity.

Several lines of evidence suggested that the defect in LD consumption in AMPK-deficient cells occurs at the level of initiation of µ-lipophagy. When *snf1Δ* and *snf4Δ* cells were labeled with Erg6-DsRed and Vph1-GFP (a vacuole membrane marker) and starved by acute GR for 3 days, no DsRed signal inside the vacuole was seen by confocal imaging, in contrast to similarly-starved WT cells ([Figure 3F](#fig3){ref-type="fig"}). Examination of *snf1Δ* cells by SXT after 1.5 days of acute GR revealed LDs were excluded from the vacuole, in contrast to WT cells undergoing acute GR, where LDs were readily taken up ([Figure 3G](#fig3){ref-type="fig"}, black arrows point to LDs). Examining full 3D SXT tomograms showed that LDs in *snf1Δ* cells had an overall larger size and that the total LD volume in these cells was increased relative to WT cells undergoing acute GR ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}), as expected if µ-lipophagy was not induced.

Autophagic bodies (ABs), but not LDs, could be seen inside the vacuole in SXT images of *snf1Δ* cells starved by acute GR ([Figure 3G](#fig3){ref-type="fig"}, white arrows point to these ABs, which are less dense than LDs because they contain fluid portions of the cytoplasm with less lipid \[[@bib48]\]). This suggested that µ-lipophagy, not bulk autophagy, is preferentially inhibited when AMPK is absent from cells starved by acute GR. Supporting this, total autophagic flux (measured using GFP release from GFP-Atg8) decreased but was not completely abolished in *snf1Δ* or *snf4Δ* cells undergoing acute GR relative to similarly starved WT cells ([Figure 3H](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}).

In addition to µ-lipophagy being blocked in AMPK-deficient cells (i.e. *snf1Δ* cells), these cells had significantly reduced ATP levels and shortened lifespans under acute GR, resembling cells undergoing gradual GR ([Figure 3---figure supplement 1D and E](#fig3s1){ref-type="fig"}). Under acute GR, therefore, AMPK activation, µ-lipophagy, and downstream ATP generation appear to be tightly linked for ensuring cell survival.

AMPK regulation under glucose starvation {#s2-6}
----------------------------------------

To analyze how AMPK is regulated under acute versus gradual GR, we examined the extent to which Snf1p is phosphorylated to become active under these conditions. Measuring Thr210 phosphorylation of Snf1p as indicator of AMPK activation ([@bib31]), we found AMPK became active within 4 hr of acute GR, whereas non-starved cells or cells undergoing gradual GR showed little AMPK activation at this time ([Figure 4A](#fig4){ref-type="fig"}). AMPK activation also remained low under gradual GR conditions when cells were incubated for 4 hr in media with rapamycin. This suggests that TOR inhibition also does not activate AMPK at this time point ([Figure 4B](#fig4){ref-type="fig"}).10.7554/eLife.21690.010Figure 4.Acute GR, but not gradual GR or rapamycin treatment, enhances AMPK activity to promote cell survival.(**A**) Phosphorylated or total Snf1p levels were determined in cells expressing Snf1-HA under no GR and gradual or acute GR for 4 hr using α-phospho AMPK (top band: HA-tagged Snf1p; lower band: endogenous Snf1p) and α-HA antibodies, respectively. (**B**) Cells harboring Snf1-HA were placed in synthetic complete (SC) media containing 2% glucose with 50 nM rapamycin (Gradual GR +rapamycin) or 0.4% glucose (Acute GR) for 4 hr. Phosphorylated or total Snf1p levels were measured as described in (**A**). (**C**) MG132 (10 μM at final concentration) was added to cells in (**A**) and the levels of phosphorylated or total Snf1p were determined as described in (**A**) at the indicated times. (**D**) The ratio of phosphorylated to total Snf1p levels was determined using data in (**C**) and was plotted as a percentage of that seen in cells undergoing acute GR at 18 hr (which was set at 100%). (**E**) Cells harboring Snf1-HA were grown under SC media with no GR, acute GR, or gradual GR with/without rapamycin treatment. The levels of phosphorylated or total Snf1p were measured as described in (**A**) at the indicated times. (**F**) Cell survival assay was performed in WT cells undergoing gradual or acute GR in the presence of rapamycin (0, 250, and 500 nM at final concentration) in SC media. Equal numbers of cells from each condition were plated onto YPEG agar media to visualize viable cells at the indicated days. Representative colony images are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.010](10.7554/eLife.21690.010)10.7554/eLife.21690.011Figure 4---figure supplement 1.TOR inhibition by rapamycin treatment or amino acid depletion obstructs cell survival during glucose starvation.(**A**) Lifespan of cells in [Figure 4F](#fig4){ref-type="fig"} was determined as described in [Figure 1A](#fig1){ref-type="fig"}. (**B**) Lifespan of cells undergoing gradual or acute GR without excessive amino acids (Amino acid depleted) or with excessive amino acids (Amino acid fed) was determined as described in [Figure 1A](#fig1){ref-type="fig"}. Data from two independent experiments are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.011](10.7554/eLife.21690.011)10.7554/eLife.21690.012Figure 4---figure supplement 2.Constitutively-active AMPK does not extend lifespan of cells undergoing gradual GR.Lifespan of WT and *reg1Δ* cells undergoing gradual GR with and without excessive amino acids (SC gradual GR and SD gradual GR, respectively) was determined as described in [Figure 1A](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.012](10.7554/eLife.21690.012)

We next examined Thr210 phosphorylation of Snf1p after longer times of acute or gradual GR ([Figure 4C and D](#fig4){ref-type="fig"}). Under acute GR, phosphorylated Snf1p levels measurably increased after 18 hr and were maintained thereafter. Under gradual GR, by contrast, significant levels of phosphorylated Snf1p were present at 18 hr, but the levels fell thereafter, becoming very low by 36 hr ([Figure 4C](#fig4){ref-type="fig"}). Notably, addition of the proteasome inhibitor MG132 to these cells at 18 hr increased total Snf1p levels at 24 hr and 36 hr ([Figure 4C](#fig4){ref-type="fig"}), although by 36 hr the phosphorylated pool of Snf1p in total Snf1p was still decreased in cells undergoing gradual GR ([Figure 4D](#fig4){ref-type="fig"}). This suggested that AMPK is activated only short-term under gradual GR because the protein and its phosphorylated form undergo rapid proteasomal degradation. By contrast, under acute GR, Snf1p and its phosphorylated form appear to be protected from degradation and therefore more stable.

Interestingly, loss of phosphorylated and total Snf1p was accelerated within 24 hr of acute GR when TOR was inhibited by rapamycin treatment ([Figure 4E](#fig4){ref-type="fig"}, Acute GR). Degradation of phosphorylated and total Snf1p also sped up during gradual GR when rapamycin was present, with Snf1p no longer detectable at 24 hr treatment ([Figure 4E](#fig4){ref-type="fig"}, Gradual GR). This indicated rapamycin treatment antagonizes AMPK activity. As µ-lipophagy depends on AMPK activation (see [Figure 3E](#fig3){ref-type="fig"}, Acute GR), this could explain why rapamycin treatment decreases µ-lipophagy under acute GR (see [Figure 3D](#fig3){ref-type="fig"}).

We next examined the effect of rapamycin treatment on cell survival under acute or gradual GR. Rapamycin treatment diminished cell viability in a dose-dependent manner under both acute and gradual GR conditions ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). A similar effect was observed when amino acids were depleted from the media (i.e., SD gradual and SD acute GR) ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Therefore, TOR inactivation is insufficient to keep cells alive under glucose restriction, potentially because it inhibits long-term AMPK activation, which is necessary to maintain µ-lipophagy.

Testing for autophagic machinery specific for µ-lipophagy {#s2-7}
---------------------------------------------------------

We next investigated whether specific autophagy factors initiate µ-lipophagy in cells undergoing acute GR. Parallel GFP-Atg8 and Erg6-DsRed flux assays (measuring bulk and LD-specific degradation, respectively) were performed in yeast cells lacking each of the 31 known autophagy-related (*ATG*) genes under acute GR ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Thirteen *ATG* genes known to be essential for general autophagy were also necessary for µ-lipophagy; including genes for autophagosome induction (i.e. *ATG1*, *ATG6, ATG13* and *ATG14*), maturation (i.e. *ATG3*, *ATG5*, *ATG7*, *ATG10*, *ATG12* and *ATG16*), and membrane retrieval (i.e. *ATG2, ATG9 and ATG18*) ([@bib33]) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This indicated that µ-lipophagy in cells undergoing acute GR depends on *bona fide* autophagosomal machinery.10.7554/eLife.21690.013Figure 5.*ATG14* is required for μ-lipophagy, ATP maintenance, and lifespan extension during acute GR.(**A**) Autophagic and LD flux assays were performed as described in [Figure 2F and D](#fig2){ref-type="fig"}, respectively. Western blot images of WT, *atg1Δ*, *atg6Δ*, *atg14Δ*, and *atg34Δ* cells grown under acute GR are shown. (**B**) Pho8Δ60 (a cytoplasmic autophagic substrate) degradation assay was performed in WT, *snf1Δ*, *atg6Δ*, *atg14Δ*, and *atg34Δ* cells harboring GFP-Pho8Δ60 during acute GR. (**C**) Representative confocal images of WT, *atg11Δ*, and *atg14Δ* cells expressing Erg6-DsRed and Vph1-GFP under acute GR are shown. White arrowheads point to vacuolar localized LD signals. Scale bar represents 5 μm. (**D**) Representative SXT images of WT, *atg11Δ*, and *atg14Δ* cells are shown. Black arrowheads point to LDs localized within the vacuole. Scale bar represents 1 μm. Right panels show full 3D SXT images (LD: green; nucleus: purple; vacuole: pale yellow; mitochondria: gold). (**E**) Percentage decrease of LD volume in acute GR compared to gradual GR was determined using full 3D SXT images of cells in (**D**). Data are expressed as mean ± SD (*n* = 7 \~ 10). \*p\<0.05 versus WT. (**F**) ATP levels of cells in (**E**) were determined as described in the Materials and methods. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions. (**G**) Lifespan of cells in (**E**) undergoing acute or gradual GR is shown as described in [Figure 1A](#fig1){ref-type="fig"}. Three biologically independent experiments are shown together.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.013](10.7554/eLife.21690.013)10.7554/eLife.21690.014Figure 5---figure supplement 1.Biochemical screening reveals differential roles of autophagy-related (*ATG*) genes in μ-lipophagy.Each indicated yeast strain containing GFP-Atg8 or Erg6-DsRed was grown under acute GR. Experiments measuring flux ratio of Atg8p or Erg6p were performed using antibodies against GFP or RFP at day 1 (D1) and day 2 (D2). (**A**) *ATG* genes that were indispensible for both Atg8p and Erg6p processing are shown. (**B**) *ATG* genes that were partially required for the Atg8p processing are shown. (**C**) *ATG* genes that were not necessary for the Atg8p processing are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.014](10.7554/eLife.21690.014)10.7554/eLife.21690.015Figure 5---figure supplement 2.*ATG14* is required for autophagy induction, while its deficiency does not block degradation of autophagosome or peroxisome during glucose starvation.(**A**) WT, *atg6Δ*, and *atg14Δ* cells harboring GFP-Atg8 were grown in YPD and placed in nitrogen starvation media for the indicated times. Autophagic flux assay was performed as described in [Figure 2F](#fig2){ref-type="fig"}. Representative western blot image is shown. (**B**) Representative images of cells in (**A**) are shown. (**C**) Percentage of cells containing less than three or more of Atg8 punctate structures was determined in cells from (**B**). Approximately 150 cells per each condition were scored. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions. (**D**) Autophagic flux assay was performed in WT, *atg1Δ*, and *atg14Δ* cells harboring GFP-Atg8 during gradual GR with excessive amino acids with/without rapamycin at the indicated times. (**E**) Pot1p degradation flux assay was performed in WT, *atg1Δ, atg11Δ*, *atg14Δ*, *atg32Δ*, and *atg34Δ* cells harboring Pot1-GFP (peroxisome marker) at the indicated days under gradual GR. (**F**) Quantification of Pot1p degradation in (**E**) is shown. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.015](10.7554/eLife.21690.015)10.7554/eLife.21690.016Figure 5---figure supplement 3.Genes required for μ-lipophagy, but not for pexophagy or mitophagy, are necessary for cell longevity during acute GR.(**A**) Long-term viability of WT, *atg1Δ*, *atg5Δ*, and *atg23Δ* cells undergoing acute GR was measured as described in [Figure 1A](#fig1){ref-type="fig"}. (**B**) Representative SXT images of *atg11Δ* and *atg33Δ* cells under gradual or acute GR for 1.5 days are shown. Arrowheads point LDs within the vacuoles. (**C**) Long-term viability of *atg32Δ* cells was measured as described in [Figure 1A](#fig1){ref-type="fig"}. Three biologically independent experiments are shown together.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.016](10.7554/eLife.21690.016)

We found that four out of the 31 *ATG* genes functioned in µ-lipophagy without complete loss of autophagy activity in acutely glucose-restricted cells: these were *ATG8, ATG14, ATG23,* and *ATG34* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). To pare down this list, we excluded *ATG8* because exogenous GFP-Atg8 necessarily rescues otherwise defective autophagic activity in *atg8Δ* cells. We removed *ATG23* because under acute GR, *atg23Δ* cells still produced some free DsRed as seen with longer exposure of the blots (data not shown). We also excluded *ATG34* since GFP release from GFP-Pho8Δ60 (a cytosolic substrate that must undergo autophagy for degradation \[[@bib28]\]) was completely blocked in *atg34Δ* cells, unlike that found in cells lacking *SNF1* or *ATG14* during acute GR ([Figure 5B](#fig5){ref-type="fig"}). This left as our candidate gene *ATG14* ([Figure 5A and B](#fig5){ref-type="fig"}).

Atg14p's role in µ-lipophagy {#s2-8}
----------------------------

Atg14p is known to be a component of phosphatidylinositol 3-kinase (PI3K) complex I, which is involved in autophagosomal membrane biogenesis. It forms a complex with Atg6p to support the lipid kinase activity of Vps34p under nitrogen starvation ([@bib4]; [@bib34]). Consistent with this role, we observed much less autophagic flux ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}) and fewer Atg8 punctate structures ([Figure 5---figure supplement 2B and C](#fig5s2){ref-type="fig"}) in *atg14Δ* cells relative to WT cells under nitrogen starvation. Additionally, when we treated cells expressing GFP-Atg8 with rapamycin and measured autophagic flux in WT, *atg1Δ*, or *atg14Δ* cells, autophagic flux was inhibited in both *atg1Δ* and *atg14Δ* cells relative to WT cells (with less inhibition in *atg14Δ* compared to *atg1Δ* cells) ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}).

In contrast to nitrogen starvation and rapamycin treatment, Atg14p was not essential for general autophagic flux under acute GR. GFP release from GFP-Atg8 ([Figure 5A](#fig5){ref-type="fig"}, GFP-Atg8 panel) or GFP-Pho8Δ60 ([Figure 5B](#fig5){ref-type="fig"}) still occurred in *atg14Δ* cells, decreasing only slightly compared to WT cells. Despite this, *atg14Δ* cells undergoing acute GR showed a significant block in LD degradation ([Figure 5A](#fig5){ref-type="fig"}, Erg6-DsRed panel), implying Atg14p's role in cells undergoing acute GR is to drive µ-lipophagy.

We tested this hypothesis with confocal imaging of Erg6-DsRed and direct visualization of LDs using SXT in *atg14Δ* cells under acute GR. No Erg6-DsRed or LD structures redistributed into the vacuole in these cells ([Figure 5C and D](#fig5){ref-type="fig"}), supporting a role of Atg14p in initiating µ-lipophagy. By contrast, Atg14p was not required for pexophagy, the specialized form of autophagy involved in degrading peroxisomes ([@bib46]): substantial degradation of the peroxisomal marker Pot1-GFP still occurred in *atg14Δ* cells under GR, whereas no Pot1-GFP degradation occurred in *atg11Δ* cells, where pexophagy is blocked ([Figure 5---figure supplement 2E and F](#fig5s2){ref-type="fig"}). Given that *ATG14* has also been shown to be dispensable for autophagic degradation of ER components ([@bib39]), we concluded Atg14p's role under acute GR is primarily to induce µ-lipophagy.

Cellular impact of *ATG14* deletion {#s2-9}
-----------------------------------

We next examined the effect of deleting *ATG14* on LD consumption rates, cellular ATP levels, and cell survival in cells undergoing acute GR. We found that *atg14Δ* cells under acute GR: had less LD volume loss relative to that of WT or *atg11Δ* cells under acute GR ([Figure 5E](#fig5){ref-type="fig"}); depleted their ATP levels significantly faster than WT cells (or pexophagy-deficient *atg11Δ* cells) under acute GR ([Figure 5F](#fig5){ref-type="fig"}); and had significantly shortened lifespans relative to WT or *atg11Δ* cells under acute GR ([Figure 5G](#fig5){ref-type="fig"}). The shortened lifespan of *atg14Δ* cells under acute GR was similar to that seen for *atg1Δ*, *atg5Δ*, and *atg23Δ* cells, which lack core general autophagy machinery (see [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [3A](#fig5s3){ref-type="fig"}). Therefore, Atg14p and other core autophagy machinery are critical for the energy metabolism and long-term survival of cells starved acutely of glucose. Other types of autophagy, including pexophagy (controlled by Atg11p) and mitophagy (controlled by Atg11p, Atg32p, and Atg33p), did not have this role ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3B and C](#fig5s3){ref-type="fig"}).

Under gradual GR (in which µ-lipophagy is not induced), *atg14Δ* cells displayed an almost identical lifespan as WT or *atg11Δ* cells, with the vast majority of these cells dead by 13 days (\>99.9%, [Figure 5G](#fig5){ref-type="fig"}). This suggested Atg14p's pro-survival role in starved cells is connected to its regulation of µ-lipophagy.

Mechanism(s) underlying Atg14p's regulation of µ-lipophagy {#s2-10}
----------------------------------------------------------

To gain insight into how µ-lipophagy induction under acute GR is regulated by Atg14p, we monitored changes in Atg14p distribution under different GR conditions. Under no GR or gradual GR, Atg14p was localized solely within the cytoplasm in a dispersed and/or punctate pattern ([Figure 6A and B](#fig6){ref-type="fig"}, and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The punctate structures co-localized with Sec13p (a subunit of the COPII vesicle coat mediating ER-to-Golgi transport) ([Figure 6C](#fig6){ref-type="fig"}), supporting prior work implicating Atg14p in the formation of pre-autophagosomal structures at ER exit sites (ERES) under nitrogen starvation conditions ([@bib15]). In contrast to this distribution, Atg14p in cells undergoing acute GR became highly enriched on the vacuole surface ([Figure 6A--C](#fig6){ref-type="fig"}). Notably, Atg14p failed to redistribute onto the vacuole surface and remained at ERES in *snf1Δ* cells undergoing acute GR ([Figure 6D](#fig6){ref-type="fig"}), in which AMPK is absent and µ-lipophagy is inhibited. Re-introduction of Snf1p-HA into *snf1Δ* cells under acute GR led to Atg14p re-localizing onto the vacuole surface ([Figure 6A and B](#fig6){ref-type="fig"}), and reversed the growth defects seen in these cells under glucose starvation ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). These results suggested that under acute GR, Atg14p redistributes in an AMPK-dependent manner from ERES to vacuolar membranes where it helps to induce µ-lipophagy. Atg14p appeared to function downstream of AMPK in this pathway because *atg14Δ* cells did not prevent AMPK (i.e. Snf1p) from being phosphorylated under acute GR ([Figure 6---figure supplement 3A](#fig6s3){ref-type="fig"}), whereas *snf1Δ* cells prevented Atg14p from re-localizing onto the vacuole (see above).10.7554/eLife.21690.017Figure 6.Atg14p is enriched on the vacuole surface upon AMPK activation during acute GR.(**A**) WT and *snf1Δ* cells harboring Atg14-3×GFP were grown under no GR, gradual GR, or acute GR for \~24 hr with or without Snf1p-HA. Representative images of Atg14p and the vacuole marker CMAC-A-P are shown. (**B**) Percentage of cells in (**A**) displaying indicated Atg14p localization patterns was determined. Approximately 100 cells per each condition were analyzed. (**C**) Cells harboring Atg14-3×GFP and Sec13-RFP were grown under gradual or acute GR for \~24 hr. Representative images of Atg14p and Sec13p are shown. (**D**) *snf1Δ* cells harboring Atg14-3×GFP and Sec13-RFP were grown under gradual or acute GR for \~24 hr. Representative images of Atg14p and Sec13p are shown. (**E**) Representative images of Atg14p in cells undergoing acute GR with excessive amino acids (i.e. SC acute GR) with/without 50 nM rapamycin (rap) for \~24 hr are shown. (**F**) Representative images of Atg14p and Sec13p in cells growing under excessive amino acids with no GR (i.e. SC no GR) or acute GR (i.e. SC acute GR) with/without 50 nM rap for \~24 hr are shown. Dashed lines and arrowheads indicate cell membrane and Atg14p signals that are co-localized with Sec13p, respectively. (**G**) Percentage of cells in (**E**) displaying indicated Atg14p localization patterns is shown. Approximately 100 cells per each condition were analyzed. Unless indicated otherwise, data from five independent measurements are shown as mean ± SD. Scale bar represents 2.5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.017](10.7554/eLife.21690.017)10.7554/eLife.21690.018Figure 6---figure supplement 1.Atg14p is localized within the cytoplasm in dispersed or punctate pattern under no GR or gradual GR.WT cells harboring Atg14-3×GFP were grown under no GR or gradual GR for \~24 hr. Representative images of Atg14p and the vacuole marker CMAC-A-P are shown. Scale bar represents 2.5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.018](10.7554/eLife.21690.018)10.7554/eLife.21690.019Figure 6---figure supplement 2.Reintroducing *SNF1*-3×HA rescues growth defects of *snf1Δ* cells under glucose starvation.WT and *snf1Δ* cells were transformed with endogenous promoter containing *SNF1*-3×HA construct and were grown under gradual GR for \~24 hr. Cells were serially diluted and plated onto YP-agar plates containing 2% glucose or 2% raffinose. Representative colony images taken after 36 hr at 30°C are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.019](10.7554/eLife.21690.019)10.7554/eLife.21690.020Figure 6---figure supplement 3.Atg14p forms a complex with Snf1p and is not required for Snf1p phosphorylation during acute GR.(**A**) Snf1p phosphorylation was measured in WT and *atg14Δ* cells growing under acute, gradual, or no GR for 4 hr using α-phospho AMPK antibody as described in the Materials and methods. (**B**) Immunoprecipitation analysis was performed in cells harboring Snf1-HA and Atg14-3×GFP, or Atg6-3×GFP after \~24 hr of acute GR as described in the Materials and methods. Equal amounts of Atg proteins were loaded for Western-blotting of Snf1p. Representative blot images are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.020](10.7554/eLife.21690.020)

Given that rapamycin treatment under acute GR inhibits µ-lipophagy, we next looked at Atg14p localization under these conditions. Notably, Atg14p did not relocate onto the vacuolar surface in rapamycin-treated cells undergoing acute GR ([Figure 6E--G](#fig6){ref-type="fig"}); instead, it localized within cytoplasmic puncta that often co-localized with Sec13p (see arrowheads in [Figure 6F](#fig6){ref-type="fig"}). Thus, Atg14p's localization to the vacuole under acute GR is antagonized by TOR inhibition (i.e. rapamycin treatment).

Immunoprecipitation experiments using cells harboring a Snf1p-HA plasmid and GFP-tagged Atg14p revealed Atg14p interacts with Snf1p-HA upon acute GR, in contrast to another autophagy-related PI3K component, Atg6p ([@bib34]), which did not significantly interact with Snf1p compared to Atg14p ([Figure 6---figure supplement 3B](#fig6s3){ref-type="fig"}). AMPK and Atg14p therefore appear to coexist in a complex under acute GR conditions.

Testing for vacuolar localization of other autophagy-related PI3K complex I components {#s2-11}
--------------------------------------------------------------------------------------

We examined whether other autophagy-related PI3K complex I components besides Atg14p (i.e., Atg6p, Atg38p, Vps15p, Vps34p, and Vps38p) relocated to the vacuole surface under acute GR to help initiate µ-lipophagy. Cells harboring Ivy1p-mCherry (a vacuole membrane marker) and GFP-tagged Atg6p, Atg38p, Vps15p, Vps34p, or Vps38p were monitored. Vacuole association of each PI3K complex I component was scored by AIRY-scan confocal microscopy image analysis. Prior to glucose starvation, Atg6p and Vps15p both showed significant association with the vacuole surface. Whereas Atg6p remained localized there after shifting to either acute or gradual GR, Vps15p redistributed off the vacuole upon acute GR ([Figure 7A and B](#fig7){ref-type="fig"}). The other PI3K complex I components (i.e. Atg38p, Vps34p, and Vps38p) remained primarily cytosolic with no increased vacuolar association upon shift to either acute or gradual GR ([Figure 7A and B](#fig7){ref-type="fig"}). This meant that only Atg6p and Atg14p reside on the vacuole surface under acute GR, potentially serving as important initiators of µ-lipophagy. In addition, only Atg14p's vacuolar localization was AMPK-dependent, since Atg6p remained prominently localized at the vacuolar surface even when AMPK was inactive (i.e. in *snf1Δ* cells or during gradual GR) ([Figure 7C](#fig7){ref-type="fig"}).10.7554/eLife.21690.021Figure 7.Atg6p and Atg14p, but not other PI3K complex I components, enrich on the vacuole surface upon acute GR.(**A**) Cells harboring GFP-tagged Atg6p, Atg38p, Vps15p, Vps34p, or Vps38p and containing lvy1-mCherry (lvy1-mCh, vacuole membrane marker) were grown under acute or gradual GR. Representative images of each indicated GFP-tagged protein and Ivy1p in cells under acute GR for \~24 hr are shown. (**B**) Cells in (**A**) or containing Atg14-3×GFP were grown under gradual or acute GR for \~24 hr. Percentage of cells displaying indicated GFP localization patterns was determined. Approximately 100 cells per each condition were analyzed. Data are expressed as mean ± SD (*n* = 3). n indicates the number of experimental repetitions. (**C**) WT and *snf1Δ* cells harboring Atg6-3×GFP were grown under acute or gradual GR for \~24 hr. Representative images of Atg6p and the vacuole marker CMAC-A-P are shown. Scale bar represents 2.5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.021](10.7554/eLife.21690.021)

Atg14p drives liquid-ordered membrane domain formation on the vacuole {#s2-12}
---------------------------------------------------------------------

Prior work has shown that when budding yeast are starved of glucose, they form distinct sterol-enriched, liquid-ordered (L~o~) domains and liquid-disordered membrane (L~d~) domains on their vacuolar surface ([@bib47]), with the L~o~ domains serving as preferential internalization sites for LDs ([@bib53]). Using GFP-Pho8 as a marker for L~d~ domains, we observed large, marker-free L~o~ domains on the vacuole membrane in cells undergoing acute GR ([Figure 8A](#fig8){ref-type="fig"}). LDs, labeled using Erg6-DsRed, resided exclusively in the L~o~ domains, consistent with the L~o~ domains serving as preferential sites for LD uptake into the vacuole. By contrast, in cells undergoing gradual GR, L~o~ domains were much less apparent, and LDs were mainly clustered near one side of the vacuole ([Figure 8B](#fig8){ref-type="fig"}). Acute GR therefore appears to drive both the formation of large L~o~ domains on the vacuole membrane and LD association with these domains.10.7554/eLife.21690.022Figure 8.Atg14p is required for the formation of vacuolar liquid-ordered membrane domains and LD recruitment to the vacuole surface during acute GR.(**A, B**) Cells harboring GFP-Pho8 (a vacuole membrane marker) and Erg6-DsRed were grown under acute or gradual GR for day 1.5 (D1.5). Representative AIRY-scan images of Pho8p and Erg6p associated with different vacuole z-position are shown. (**C**) Cells harboring Atg14-3×GFP and Vph1-mCherry (a liquid disordered membrane maker that is excluded from liquid-ordered domains \[[@bib47]\]) were grown under acute GR for D1.5. Representative z-slice and maximum projection images of Atg14p and Vph1p are shown. (**D**) Cells harboring Atg6-3×GFP and Vph1-mCherry were grown under acute GR for D1.5. Representative images of Atg6p and Vph1p are shown. (**E**) WT, *atg14Δ*, *atg6Δ*, and *snf1Δ* cells harboring Vph1-GFP were grown under acute or gradual GR. Representative images of Vph1p at different days are shown. (**F**) Percentage of cells displaying indicated GFP localization patterns on the vacuole was scored. Approximately 150 cells per each condition were analyzed. Scale bar represents 2.5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.022](10.7554/eLife.21690.022)10.7554/eLife.21690.023Figure 8---figure supplement 1.Atg14p and LDs possibly interact on the vacuole liquid-ordered membrane domains upon acute GR in a Snf1p-dependent manner.WT and *snf1Δ* cells harboring Atg14-3×GFP and Erg6-DsRed were grown under acute or gradual GR for day 1.5. Representative AIRY-scan images of Atg14p, Erg6p, and DAPI are shown. Scale bar represents 2.5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.023](10.7554/eLife.21690.023)

We next used AIRY-scan confocal microscopy to visualize the vacuolar localizations of Atg14p, Atg6p and a different vacuole L~d~ domain marker, Vph1-mCherry ([@bib47]) under acute GR. 3D volume reconstruction and maximum projection images revealed Atg14p molecules localizing as punctate elements within vacuolar L~o~ domains ([Video 3](#media3){ref-type="other"} and [Figure 8C](#fig8){ref-type="fig"}). Single z-slices from these images showed Atg14p was preferentially localized on the edges of L~o~ domains ([Figure 8C](#fig8){ref-type="fig"}, Single z-slice), in close association with LDs ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Atg6p also localized in L~o~ domains at the vacuole surface but was more broadly distributed relative to Atg14p ([Figure 8D](#fig8){ref-type="fig"}).Video 3.Vacuolar organization of Atg14p and Vph1p during acute GR.Movie of a cell from [Figure 8C](#fig8){ref-type="fig"} showing 3D organization of Atg14p (green) and Vph1p (red) is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.024](10.7554/eLife.21690.024)10.7554/eLife.21690.024

To address whether Atg14p and/or Atg6p are critical for creating the large L~o~ domains on vacuole membranes under acute GR, we deleted the gene for each protein and then examined whether or not L~o~ domains were formed. Little or no L~o~ domains were observed in either *atg14Δ* or *atg6Δ* cells under acute or gradual GR, with the effect most potent in *atg6Δ* cells ([Figure 8E and F](#fig8){ref-type="fig"}). Given that Atg6p resides on the vacuole membrane irrespective of the starvation condition (see [Figure 7C](#fig7){ref-type="fig"}), the results suggested Atg14p triggers large-scale L~o~ formation under acute GR, with a critical supportive role played by Atg6p. Consistent with this, fewer large-scale L~o~ domains formed in *snf1Δ* cells under acute GR ([Figure 8E and F](#fig8){ref-type="fig"}), a condition where Atg6p resides on the vacuole surface but Atg14p is not recruited there (see [Figure 6D](#fig6){ref-type="fig"}).

Discussion {#s3}
==========

A key nutrient in the cell's decision whether or not to proliferate is glucose. In its presence, cells grow/divide; in its absence, cells instead switch on catabolic pathways (e.g. autophagy and fatty acid breakdown) and OXPHOS, which allow long-term survival until glucose becomes available again ([@bib16]; [@bib21]; [@bib54]). The underlying mechanism(s) for this response, including the relevant signaling and organellar systems, is unclear yet it is fundamental for understanding cell behavior under various physiological conditions. Here, we used budding yeast as a model system to study this survival response, focusing on the key players and pathways. We found that for cells to survive long-term under full nutrient starvation, they need AMPK/Snf1p, the cell's major ATP sensor, to be activated and stabilized. This occurred when cells sensed an acute depletion of glucose at the beginning of starvation (i.e. acute GR). This induced the pathways for µ-lipophagy, general autophagy, OXPHOS and stress resistance necessary for long-term survival. In contrast, all these pathways were attenuated and cellular lifespan shortened in cells lacking AMPK activity (i.e. *snf1Δ* cells). The finding that AMPK acts as a critical upstream regulator of yeast cell survival under starvation supports prior work in *C. elegans* similarly implicating AMPK's role in lifespan extension under dietary restriction ([@bib19]; [@bib40]).

Other nutrient depletion conditions besides acute GR, including rapamycin treatment or gradual GR, did not maintain AMPK activity once it was switched on, and resulted in shortened cellular lifespans. We speculate this effect arose because TOR is inhibited early on by these treatments: this would induce bulk autophagy and cause a surplus in amino acids, raising ATP levels to antagonize AMPK activity. While rapamycin treatment directly inhibits TOR, gradual GR would do so by causing cells to sense amino acid depletion before glucose reduction from the medium, leading to TOR inhibition and its prevention of AMPK activation. This can explain why no sustained AMPK activation or enhanced longevity occurred under gradual GR, even in cells lacking Reg1p (the phosphatase that dephosphorylates Snf1p \[[@bib7]\]) ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}).

Further work is needed to understand at the molecular level how TOR inhibition antagonizes AMPK activation under gradual GR. However, prior work has demonstrated that mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system ([@bib60]), and we found that both rapamycin and gradual GR treatments caused proteasomal degradation of AMPK (in contrast to acute GR treatment, which resulted in long-term AMPK activation).

A key survival promoting role of AMPK under acute GR that we observed was the induction of µ-lipophagy, which by causing LDs to be digested provides precursors for mitochondrial energy production in the absence of glucose. In support of this role, cells undergoing acute GR with genes deleted for AMPK (i.e. *snf1Δ* cells) showed diminished LD consumption rates - comparable to those of cells undergoing gradual GR (where AMPK activation is not maintained). The conclusion that LD consumption in cells undergoing acute GR occurred by µ-lipophagy arose from two observations. First, LD consumption was autophagy-dependent; deletion of core autophagy genes blocked it (and caused diminished cell lifespan). Second, LDs were directly taken up into the vacuole, as interpreted from our results using SXT and AIRY-scan imaging and prior work using transmission EM ([@bib52]).

To determine what autophagic component(s) are essential for initiating µ-lipophagy under acute GR, we screened a yeast library of known autophagy genes. Under acute GR, *ATG14* was at the same time necessary for µ-lipophagy and unnecessary for general autophagy. No other gene had these characteristics, pointing to Atg14p (a subunit of the PI3K complex I) as a major component necessary for µ-lipophagy under acute GR. That said, *ATG14* was required for general autophagy under nitrogen starvation or rapamycin treatment, as previously reported ([@bib24]; [@bib26]). Thus, there appears to be a fundamental plasticity in the regulation and function of core autophagy components under different starvation conditions- with Atg14p directing bulk autophagy under TOR inhibition, but driving µ-lipophagy under AMPK activation (i.e. acute GR).

To understand how Atg14p could be modulated to control different autophagy pathways, we examined its subcellular localization upon induction of different autophagic pathways. Under gradual GR or rapamycin treatment (where TOR is inhibited and bulk autophagy induced), Atg14p was enriched on punctate elements in the periphery of cells. These structures represented ERES, whose elements have previously been shown to recruit Atg14p in an early step in autophagosomal biogenesis ([@bib13]; [@bib15]). By contrast, during acute GR (where AMPK is active and µ-lipophagy is induced), Atg14p became enriched on the vacuole membrane, localizing to L~o~ domains defined by lack of vacuolar Vph1p labeling ([@bib47]). Inhibiting TOR through rapamycin treatment during acute GR caused Atg14p to redistribute back to ERES, and also led to blocking of µ-lipophagy. Thus, Atg14p shifts its distribution under different starvation regimens to facilitate different autophagic pathways.

What causes Atg14p's redistribution from ERES/cytosol onto the vacuolar surface upon acute GR remains unclear but could be related to the physical interaction between Snf1p and Atg14p that we observed arising under these conditions. This interaction could help stabilize Snf1p against proteasomal degradation (occurring when TOR is inactivated or under glucose-rich conditions) and may signal Atg14p's redistribution from ERES onto the vacuole.

Atg14p's role on the vacuole surface is likely related to the formation of large L~o~ domains (see [Figure 9](#fig9){ref-type="fig"}), which are proposed to function as entry portals for LD uptake into the vacuole ([@bib53]). We observed that LDs dock exclusively at L~o~ domains on the vacuole surface. That Atg14p helps stabilize/form these large L~o~ domains is supported by our findings that: (1) Atg14p localizes on the rims of these domains, (2) deletion of Atg14p abolishes the domains, and (3) conditions that prevent Atg14p from redistributing onto the vacuole (including deletion of *SNF1*, rapamycin treatment, or gradual GR) diminishes the L~o~ domains and results in no LD uptake into the vacuole.10.7554/eLife.21690.025Figure 9.Model for AMPK-Atg14p-dependent L~o~ domain formation on the vacuole and its role in μ-lipophagy during acute GR.In cells undergoing acute GR, LDs and the vacuole coordinate to mediate μ-lipophagy. This response involves AMPK/Snf1p activation and Atg14p redistribution to liquid-ordered membrane (L~o~) domains on the vacuole surface. Atg14p in cells starved by gradual GR, where AMPK is inactive, does not associate with the vacuole, and instead resides at ER exit sites (ERES). Under acute GR, vacuole-associated Atg14p preferentially resides on the edges of L~o~ domains and drives large-scale L~o~ domain formation in concert with Atg6p. The enlarged L~o~ domains now serve as LD recruitment sites, with LDs moving to the vacuole from the perinuclear ER area. LDs on the L~o~ domain then bud into the vacuolar lumen and undergo degradation to recycle stored fat molecules, resulting in the extension of lifespan of starved cells during acute GR.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.025](10.7554/eLife.21690.025)

In examining the subcellular distribution of other autophagy-related PI3K complex I components (including Atg6p, Atg38p, Vps15p, Vps34p and Vps38p), we found that only Atg6p resides on the vacuole surface with Atg14p under acute GR conditions. Atg6p interacts with Atg14p to form a PI3K complex involved in autophagy ([@bib26]), so we studied Atg6p's distribution under different starvation conditions. Unlike Atg14p, Atg6p resided on the vacuole whether cells were fed or starved. Under acute GR, when large L~o~ domains formed, Atg6p localized within these large domains. Deletion of *ATG6* prevented any L~o~ domain formation under acute GR. This suggested Atg6p works in conjunction with Atg14p to generate the large L~o~ domains, with Atg14p crucial for triggering L~o~ domain formation ([Figure 9](#fig9){ref-type="fig"}). Exactly how Atg14p could stimulate vacuolar micro-domain formation is unclear, but it may involve LDs themselves, which by contributing sterols to the vacuolar surface could stimulate micro-domain formation, as suggested by [@bib53].

LDs play other role(s) during starvation than simply providing an alternate carbon source for energy production when glucose is absent. This includes supplying lipids for bulk autophagy ([@bib12]; [@bib43]), and serving as a reservoir for stress-induced excess/damaged lipids ([@bib51]). While important, these other LD functions are not sufficient for cells to survive long-term under nutrient starvation unless LD consumption is occurring by µ-lipophagy. Evidence supporting this came from our findings that in glucose-starved cells in which µ-lipophagy is absent (i.e. *atg14Δ* cells, *snf1Δ* cells, cells under gradual GR, or rapamycin-treated cells), less energy is produced relative to cells engaged in µ-lipophagy, and cells survive only short-term. Selective autophagy pathways such as mitophagy or pexophagy have been suggested to be important in the long-term survival of starved cells through organellar quality control ([@bib25]; [@bib41]; [@bib46]). That µ-lipophagy is more significant than either of these for cell longevity under starvation by acute GR conditions was suggested by our findings that in mitophagy-deficient (e.g. *atg32Δ* and *atg33Δ*) cells or pexophagy-deficient *atg11Δ* cells, µ-lipophagy and long-term survival still occurred.

In summary, our data demonstrate that AMPK and vacuole-associated Atg14p activities play critical roles in cell survival under acute GR by triggering µ-lipophagy ([Figure 9](#fig9){ref-type="fig"}). The key step for this process is early onset AMPK signaling caused by acute GR. This leads to the relocation of Atg14p, which also physically interacts with AMPK/Snf1p, from ERES to the vacuole. On the vacuole surface, Atg14p initiates µ-lipophagy by working in conjunction with Atg6p and other core autophagy machinery. Through their cooperative roles in promoting µ-lipophagy, these components enable yeast cells undergoing acute GR to dramatically extend their lifespans relative to cells experiencing gradual GR or rapamycin treatment. Cells only preserved Snf1p activity and stimulated µ-lipophagy when Snf1p was activated as a consequence of acute glucose depletion (no similar response occurred when TOR was deactivated by amino acid loss or rapamycin treatment). This supports the notion that AMPK activation selectively promotes autophagic recycling of stored carbon-energy sources (e.g. lipids), while TOR inhibition activates autophagy pathways leading to recycling of nitrogen sources (i.e. digestion of protein-enriched compartments). Thus, under different nutrient stresses, yeast cells choose distinct autophagic pathways for digestion of different substrates (e.g. lipids versus amino acids) to optimize cell metabolism and survival. Given the shared cellular machinery between yeast and other organisms, these findings are germane to understanding cell survival mechanisms under different starvation regimens and should be relevant for clarifying cellular mechanisms for abnormal metabolic processes associated with cancer, obesity and aging.

Materials and methods {#s4}
=====================

Yeast strains, plasmids, and media {#s4-1}
----------------------------------

Yeast BY strains and plasmids used in this study are listed in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}. Rich medium (YPD) containing 2% glucose and synthetic dextrose minimal (SD) or complete (SC) media containing either 2% glucose or 0.4% glucose were prepared as described by [@bib2]. YPD medium containing 1% (wt/vol) Bacto yeast extract, 2% (wt/vol) Bacto peptone, and 2% (wt/vol) dextrose was prepared. Synthetic base medium containing 0.17% (wt/vol) Difco yeast nitrogen base without amino acids and ammonium sulfate, 0.5% (wt/vol) ammonium sulfate, and 10 mM K~2~HPO~4~ was prepared at 80% of the final volume. Solid plates were made by adding 1.6% (wt/vol) Bacto agar. For synthetic complete media, 0.067% (wt/vol) of Complete Supplement Mixture minus leucine and uracil (MP Biomedicals) was prepared using the aforementioned synthetic base medium. These media were autoclaved at 121°C for 15 min. Stock solutions for supplemental amino acids, nucleic acid bases, and dextrose (20% wt/vol) were prepared according to Sherman et al. ([@bib42]), were filter-sterilized, and were added as needed to make SD or SC media. A final concentration (250 μg/mL) of the antibiotic G~418~ sulfate (Mediatech Inc.) was supplied if possible to culture media except the culture conditions for CWY7183, CWY7226, AYS1701, AYS1703, AYS1704, AYS1705, and AYS1706. The final volume was adjusted to 100% with sterile water. To generate pUC19-URA3-3'SEC13-yemRFP, yeast-enhanced mRFP (yemRFP) was amplified from pRS415-yemRFP by PCR using the following primers: 5'-aatgggaacccgctggtgaagttcatcagtacgatccaccggtcgccaccatggtttcaaaaggtgaagaagataatatggc and 3'-ttttcttttgagatgtttcattttaaattcttgatactacggccgctttatttatataattcatccataccaccagttgaatgtc. The PCR product was used to replace GFP from pUC19-URA3-3'SEC13-GFP ([@bib38]).10.7554/eLife.21690.026Table 1.List of yeast strains.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.026](10.7554/eLife.21690.026)StrainGenotypeSourceBY4742*MATα*, *his3∆*1, *leu2∆*0, *lys2∆*0, *ura3∆*0([@bib8])WTBY4742 *ho∆::KanMX4*([@bib56])*snf1∆*BY4742 *snf1∆::KanMX4*EUROSCARF*snf4∆*BY4742 *snf4∆::KanMX4*"*atg1∆*BY4742 *atg1∆::KanMX4*"*atg2∆*BY4742 *atg2∆::KanMX4*"*atg3∆*BY4742 *atg3∆::KanMX4*"*atg5∆*BY4742 *atg5∆::KanMX4*"*atg6∆*BY4742 *atg6∆::KanMX4*"*atg7∆*BY4742 *atg7∆::KanMX4*"*atg8∆*BY4742 *atg8∆::KanMX4*"*atg9∆*BY4742 *atg9∆::KanMX4*"*atg10∆*BY4742 *atg10∆::KanMX4*"*atg11∆*BY4742 *atg11∆::KanMX4*"*atg12∆*BY4742 *atg12∆::KanMX4*"*atg13∆*BY4742 *atg13∆::KanMX4*"*atg14∆*BY4742 *atg14∆::KanMX4*"*atg15∆*BY4742 *atg15∆::KanMX4*"*atg16∆*BY4742 *atg16∆::KanMX4*"*atg17∆*BY4742 *atg17∆::KanMX4*"*atg18∆*BY4742 *atg18∆::KanMX4*"*atg19∆*BY4742 *atg19∆::KanMX4*"*atg20∆*BY4742 *atg20∆::KanMX4*"*atg21∆*BY4742 *atg21∆::KanMX4*"*atg22∆*BY4742 *atg22∆::KanMX4*"*atg23∆*BY4742 *atg23∆::KanMX4*"*atg24∆*BY4742 *atg24∆::KanMX4*"*atg26∆*BY4742 *atg26∆::KanMX4*"*atg27∆*BY4742 *atg27∆::KanMX4*"*atg29∆*BY4742 *atg29∆::KanMX4*"*atg31∆*BY4742 *atg31∆::KanMX4*"*atg32∆*BY4742 *atg32∆::KanMX4*"*atg33∆*BY4742 *atg33∆::KanMX4*"*atg34∆*BY4742 *atg34∆::KanMX4*"*atg36∆*BY4742 *atg36∆::KanMX4*"*tgl3∆*BY4742 *tgl3∆::KanMX4*"*tgl4∆*BY4742 *tgl4∆::KanMX4*"AYS1501*ATG14-3xGFP::HIS* WTThis studyAYS1503*ATG14-3xGFP::HIS snf1∆*"AYS1506*ATG6-3xGFP::HIS* WT"AYS1508*ATG6-3xGFP::HIS snf1∆*"AYS1601*ATG14-3xGFP::HIS SEC13-yemRFP::URA3* WT"AYS1602*ATG14-3xGFP::HIS SEC13-yemRFP::URA3 snf1∆*"CWY7183*ATG6-3xGFP::HIS VPH1-mCherry:LEU* BY4742([@bib53])CWY7226*ATG14-3xGFP::HIS VPH1-mCherry:LEU* BY4742"YPJ1075BY4742 *dga1∆ lro1∆::KanMX4*([@bib37])YPJ1076BY4742 *are1∆ are2∆::KanMX4*"YPJ1078BY4742 *dga1∆ lro1∆ are1∆ are2∆::KanMX4*"BY4741*MATa*, *his3∆*1, *leu2∆*0, *met15∆*0, *ura3∆*0([@bib8])AYS1701*ATG6-3xGFP::HIS p416-Ivy1-mCherry* WTThis studyAYS1703BY4741 *ATG38-GFP::HIS p416-Ivy1-mCherry*"AYS1704BY4741 *VPS15-GFP::HIS p416-Ivy1-mCherry*"AYS1705BY4741 *VPS34-GFP::HIS p416-Ivy1-mCherry*"AYS1706BY4741 *VPS38-GFP::HIS p416-Ivy1-mCherry*"[^1]10.7554/eLife.21690.027Table 2.List of plasmids.**DOI:** [http://dx.doi.org/10.7554/eLife.21690.027](10.7554/eLife.21690.027)PlasmidOrganellesReferencepCuGFP-AUT7Autophagosome([@bib27])pRS316-PGK-POT-GFPPeroxisome([@bib6])pERG6-mDsRedLipid droplet"pRS416 Vph1-GFPVacuole([@bib11])pRS426 GFP-Pho8Vacuole"p416-Ivy1-mCherryVacuole([@bib47])pVT100U-mtGFPMitochondria([@bib55])pBS-ATG6-3xGFP-His3Autophagosome([@bib53])pBS-ATG14-3xGFP-His3Autophagosome"pRS416-P~GPD~-GFP-Pho8∆60-T~cyc1~"pRS315-SNF1-3xHA([@bib31])pUC19-URA3-3'SEC13-yemRFPER exit siteThis study

Yeast growth, glucose restriction, and genetic manipulations {#s4-2}
------------------------------------------------------------

Glucose restriction (GR) experiment was performed with SD and SC media containing either 2% (wt/vol) glucose (gradual GR) or 0.4% (wt/vol) glucose (acute GR). For non-starvation (no GR) conditions, yeast cells grown under YPD or SD and SC media containing 2% glucose were analyzed when they are in an early log phase (OD~600~ \< 0.4). Briefly, yeast strains from frozen permanent stocks at −80°C were patched onto YPD agar plates. After 2 days of growth at 30°C, cells from patches were inoculated into 5 mL of YPD in 14 mL polypropylene tubes and grown overnight at 30°C in a shaker at \~250 rpm. After \~18 hr, the yeast culture was diluted 1/100 into 5 mL of 2% glucose SD (or SC) medium and grown overnight at 30°C in a shaker at \~250 rpm. After \~18 hr, 0.05 \~ 0.1 OD Unit (OD~600~**×** mL) of yeast cells was transferred to fresh 5 mL of either 2% glucose SD (or SC) for gradual GR or 0.4% glucose SD (or SC) for acute GR. Then, cells were grown at 30°C in a shaker at \~250 rpm without nutrient replenishment to induce glucose starvation. In the case of LD defective cells (i.e. LDΔ, SEΔ, and TAGΔ cells), which completely failed to grow under the above gradual or acute GR conditions, glucose starvation was induced by transferring cells grown under YPD media directly to 2% glucose SD. The OD~600~ was routinely measured on days 1, 2, and 3 to confirm culture saturation by using Beckman DU-640 spectrophotometer (Beckman Coulter Inc.). The transformants were generated as described using EZ-Yeast Transformation Kit (MP Biomedicals).

Drug treatment {#s4-3}
--------------

Rapamycin (Cell Signaling Technology Inc.) was dissolved in dimethyl sulfoxide (DMSO) to make 1 mM stock solution and added to SC media containing 2% or 0.4% glucose at 40, 50, 100, 250, or 500 nM concentration. MG132 (Sigma-Aldrich Inc.) was dissolved in DMSO to make 10 mM stock solution and added to SD medium with 2% glucose at 10 μM concentration. For vacuole staining, CMAC-Ala-Pro (7-amino-4-chloromethylcoumarin-L-alanyl-L-proline amide, Thermo Scientific Inc.) was dissolved in DMSO to make 10 mM stock solution and added to 200 μL of yeast cultures at 100 μM concentration, followed by 4 hr incubation at 30°C before imaging experiments. For lipid droplet staining, Nile red (Thermo Scientific Inc.) was dissolved in DMSO to make 1 mg/mL stock solution and added to 500 μL of yeast cultures at 1 μg/mL concentration, followed by 15 min incubation at 30°C before imaging experiments.

Cell lifespan, cellular respiration and stress resistance measurements {#s4-4}
----------------------------------------------------------------------

Cell lifespan/viability was evaluated by using a vital dye (i.e. erythrocin B) or by the method of [@bib3]. The rate of oxygen consumption was monitored using a Clark-type oxygen electrode (Oroboros Instruments Corp.). During a cell lifespan experiment, cell cultures (1.5 mL) were transferred to an airtight chamber maintained at 30°C with magnetic stirrer, and oxygen content was monitored for at least 20 min according to the manufacturer's instructions with slight modification. The rate of oxygen consumption was normalized with OD~600~. Sensitivity to oxidative stress-inducing agents (i.e. 2.5 mM hydrogen peroxide and 30 μM menadione) was measured by determining colony forming units (CFUs) per mL of yeast culture. Briefly, 1 hr prior to stress resistance test, YPD agar plates with or without previously indicated oxidative stressors were freshly prepared. During lifespan measurement, a serial fivefold diluted culture was plated onto the aforementioned agar plates. These replica plates were incubated further at 30°C for 3 days to visualize viable colonies.

Autophagic flux and LD degradation assays {#s4-5}
-----------------------------------------

Degradation flux of autophagosomes, cytosolic autophagic substrates, peroxisomes, and LDs were performed according to Alvers et al. ([@bib3]) with slight modification using α-RFP (Ajay Sharma, CBMP, NICHD) or α-GFP (Abcam, \# ab290) antibodies.

Yeast cell lysis, immunoprecipitation, AMPK phosphorylation analysis {#s4-6}
--------------------------------------------------------------------

Cell lysates were prepared by a glass-bead method using immunoprecipitation (IP) buffer (0.1% NP-40 (4-nonylphenyl poly(ethyleneglycol), 50 mM Tris-HCl pH8, 150 mM NaCl, and 0.1 mM DTT (4-dithiothreitol)) or CHAPS buffer (1% CHAPS (3-\[(3-cholamidopropyl) dimethylammonio\]-1-propanesulfonate), 25 mM Hepes, 2 mM MgCl~2~, and 100 mM NaCl) with Halt Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific Inc.). For IP experiments, 25 OD Unit of yeast cells were collected and washed once with cold IP or CHAPS buffers. Cell pellets were resuspended with 0.5 mL IP or CHAPS buffers in 2-mL microfuge tube containing 0.25 g of 0.5 mm glass beads (Sigma-Aldrich Inc.). Then, the tube was placed on a vortex mixer at 4°C for 20 min. Cell lysates were centrifuged at top speed at 4°C for 15 min and supernatants were transferred to fresh tube with 30 μL of Protein A-Sepharose4B (Thermo Scientific Inc.) pre-treated with 2 μL of rabbit α-GFP (Ajay Sharma, CBMP, NICHD) or total rabbit IgG (Thermo Scientific Inc.). All tubes were incubated at 4°C on a rotator. After 1 hr incubation, beads were pelleted at 10,000 rpm for 10 s at 4°C and then resuspended and washed 3 times in 1 mL cold IP or CHAPS buffers. To remove NP-40, beads were washed twice in IP buffer without NP-40 and DTT. After removing all remaining buffer, beads were resuspended with 60 μL of 2X Laemmli sample buffer, boiled for 5 min, and centrifuged at top speed at 4°C for 5 min. Samples were stored at −80°C prior to performing Western blot analysis.

For AMPK phosphorylation experiments, 5 OD Unit of yeast cells were centrifuged at 2000 rpm at 4°C for 5 min and the pellets were immediately frozen by liquid nitrogen. Using cold IP buffer containing 0.25 g of 0.5 mm glass beads, cell pellets were homogenized to extract proteins as described in the above. Afterwards, BCA protein assay (Thermo Scientific Inc.) was performed to determine protein concentrations. The same amount of proteins (i.e. 10 or 15 μg) was used for western blot analysis. In addition, protein loading was monitored using TGX Stain-Free Precast Gels System (Bio-Rad Laboratories) according to the manufacturer's instructions. Phosphorylated and total Snf1p was determined as modified from McCartney and Schmidt ([@bib31]) using α-phospho AMPK (Cell Signaling, \#2535) and α-HA tag HRP (Abcam, \#ab128131) antibodies, respectively.

Cell survival measurements under rapamycin {#s4-7}
------------------------------------------

Freshly prepared yeast patch was inoculated into 5 mL of SC media containing 2% glucose and was grown at 30°C in a shaker at \~250 rpm. After \~18 hr, the cell culture was diluted 1/100 into 5 mL of SC media containing 2% or 0.4% glucose. After \~18 hr, cells were diluted by the equal volume of the corresponding media that contain 0.5 or 1 μM rapamycin, followed by growing them at 30°C in a shaker at \~250 rpm. At the indicated times, 0.00046 OD Unit cells were plated onto YPEG (1% Bacto yeast extract, 2% Bacto peptone, 2%(vol/vol) ethanol, 3%(wt/vol) glycerol) agar plate after four serial fivefold dilutions. These plates were incubated further at 30°C for 4 days to visualize viable colonies.

ATP measurements {#s4-8}
----------------

Two OD Unit of yeast cells are collected in 1.5-mL microfuge tube by centrifugation at top speed for 1 min and washed once with cold distilled water. Supernatant was removed and 0.75 mL of 90% acetone was added to the pellet. Resuspended cells were heated at 90°C to allow the acetone to evaporate off for 30 min. Approximately 50 μL of solution is remaining. Assay buffer (10 mM Tris pH8.0 and 1 mM EDTA) was added to make it to the final volume of 500 μL. The concentration of ATP was then measured according to ATP Determination Kit (Thermo Scientific Inc.) by following the manufacturer's instruction using a luminescence microplate reader (BioTek U.S.).

Microscopy {#s4-9}
----------

Soft X-ray images of cryogenic yeast samples were collected using XM-2, the National Center for X-ray Tomography soft X-ray microscope at the Advanced Light Source of Lawrence Berkeley National Laboratory and reconstructed according to previously published protocols ([@bib29]). Organelles were segmented for data analysis according to [@bib49]. Epifluorescence images of live cells were acquired using EVOS FL Cell Imaging System (Thermo Scientific Inc.) equipped with DAPI (357/44 Ex; 447/60 Em), GFP (470/22 Ex; 510/42 Em), and RFP (531/40 Ex; 593/40 Em) light cubes. Confocal fluorescence images of live cells were acquired using Leica SP5 equipped with white light laser (WLL) (Leica Microsystems) or a customized Nikon TiE inverted scope equipped with a Yokogawa spinning-disk head (\#CSU-X1, Yokogawa) and a Photometrics EM-CCD camera (Evolve 512). 488 and 561 nm or 563 nm WLL lines were used for exciting GFP and DsRed, respectively, and the emission signals were sequentially collected to minimize crosstalk. To image cells, 5 μL of cell cultures was mounted directly under a coverglass or 200 μL of cell cultures were plated and incubated in NuncLab-Tek II Chambered Coverglass (Thermo Scientific Inc.) at RT. Fixed cells were imaged using Zeiss LSM 880 Airyscan microscopy with a 63× Plan-Apochromat 1.4 NA oil objective (Carl Zeiss). DAPI, GFP, and DsRed were excited with 405, 488, and 561 nm lines, respectively, and the raw image data was processed using the commercial Zen software package (Carl Zeiss) and Imaris software (Bitplan), or ImageJ (National institutes of Health).

Yeast fixation for AIRY-scan imaging {#s4-10}
------------------------------------

Cells were fixed using cold 4% paraformaldehyde with 3.4% sucrose at RT for 15 min. Then, cells were washed twice with KPO4/Sorbitol (0.1M potassium phosphate pH7.5 1.2M sorbitol). Afterwards, cell pellets were resuspended in 50 μL KPO4/Sorbitol with DAPI at 1 μg/mL concentration and were incubated at RT for 10 min. After washing twice with KPO4/Sorbitol, cells were resuspended in Vectashield Mounting Medium (Vector Laboratories), were mounted directly under a coverglass, and were placed at RT for \>3 hr to stabilize the mount before performing imaging experiments.

Statistical analysis {#s4-11}
--------------------

Statistical analysis was performed using Prism four for Student's t-test and Grubbs' test (GraphPad Software Inc.). The significance level was set at p\<0.05.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Atg14 Redistributes from ER Exit Sites to Vacuolar Domains to Drive Lipophagy upon AMPK Activation by Glucose Starvation\" for consideration by *eLife*. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by Vojo Deretic as the Reviewing Editor and Vivek Malhotra as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this work, the authors describe how yeast carry out, under certain physiological conditions, a variant of lipophagy (autophagic degradation of neutral lipid stores often referred to as lipid droplets) through vacuolar uptake of lipid droplets/bodies. This process morphologically resembles microautophagy and in its genetic requirements and requires Atg14 re-positioning from ER exit sites to the vacuole. Curiously, inhibition of mTOR inhibits this process (unlike in the majority of other autophagic processes where mTOR conventionally plays a negative regulatory role).

The initial reviews ranged from significant to minimal experiments and revisions. This led to a discussion that resulted in the following consensus recommendation:

Please address points 1 and 2 experimentally (with details clearly outlined by the reviewers in the section reporting complete reviewers\' comments), and point 3 textually (details from reviewing editor given below).

Essential revisions:

1\) The events post Atg14 association to the vacuole in the clearance of lipid droplet are not clear. The data that Atg14 localizes to ergosterol enriched domains is not convincing ([Figure 7](#fig7){ref-type="fig"}). What other components are recruited to the ergestorol enriched vacuolar domains? The details are clearly outlined by the reviewers in the section reporting complete reviewers\' criticisms.

2\) Is the effect of lipophagy on cell survival direct? The reviewers have suggested experiments that could potentially help address this concern. What is the effect of deletion of regulators of Snf1 on cell survival? The details are clearly outlined by the reviewers in the section reporting complete reviewers\' criticisms.

Complete reviewer comments:

*Reviewer \#1:*

In the present manuscript, Seo et al. delineate principle regulatory differences of yeast cells transitioning to stationary phase in the presence of high (2%) or medium (0.4%) glucose concentrations critically determining chronological lifespan. Specifically, yeast cells activate a sustained autophagy response, which includes the selective turnover of lipid droplets (lipophagy), when AMP-dependent kinase Snf1 is stabilized and activated in the presence of low glucose (0.4%). Snf1 activity is required for re-localization of Atg14, a subunit of the phosphatidylinositol-3 kinase complex I that can also physically interact with Snf1 as shown in this manuscript, from ER exit sites to vacuoles and function in lipophagy without affecting general autophagy. Snf1 and Atg14 function is required for the long lifespan of yeast cells during chronological aging in the presence of low glucose concentrations.

The manuscript presents data that indicate important differences in the regulation of autophagy and cell metabolism dependent on glucose concentrations and critical consequences for cell survival during starvation. Furthermore, the data further evidence for fundamental plasticity in the regulation and function of core autophagy components defined by metabolic or stress conditions. Hence the findings in the present study will be of great interest in the autophagy and aging field. However, before supporting publication, two main points need to be addressed.

1\) What is the relative contribution of sustained general autophagy and selective lipophagy for cell survival?

The authors provide evidence indicating that conditions inducing lipophagy are correlated with longevity during acute GR. This conclusion depends mainly on the phenotypes associated with deletion of Snf1 or Atg14. However, it is important to note that the deletion of atg14 strongly compromises non-selective turnover of a cytosolic model substrate (GFP-Pho8d60) after two days of acute GR raising the possibility that general autophagy defects contribute to or cause shortened lifespan of this mutant. In addition, AMPK/Snf1 deletion compromises the regulation of a number of cellular functions other than lipophagy including fatty acid synthesis, mitochondrial activity, and b-oxidation of fatty acids, which likely contribute to the shortened phenotype observed for this mutant.

First, to strengthen the postulated role for lipophagy in lifespan regulation, the authors should measure wild type cell survival in SC media in the presence or absence of rapamycin during gradual and acute GR. As shown in [Figure 3C and D](#fig3){ref-type="fig"}, addition of rapamycin does not affect the general autophagy response judged by GFP-Atg8 turnover, but selectively reduces lipophagy (Erg6-DsRed turnover) to rates observed for gradual GR. Thus, if lipophagy plays a central role under these conditions, one would expect a dramatically shortened lifespan upon addition of rapamycin during acute GR.

Second, the authors show that deletion of atg14 decreases cell survival during acute GR, but do not formally demonstrate that defects in other core autophagy components (*atg1, atg5, atg23*) reduce lifespan.

Third, the authors should test whether lipid droplets are required for long chronological lifespan by testing cells that are defective in the biogenesis of lipid droplets.

2\) The lipophagy-specific function of Atg14 is unexpected and intriguing. However, in which capacity Atg14 functions in lipophagy remains underdeveloped, since the authors included only Atg6 in their analysis. The authors should analyse the remaining components of the PI3 kinase complexes including Vps34, Vps15, Vps38, and Atg38.

The physical interaction between Atg14 and Snf1 is interesting, but its significance is unclear. Is this interaction specific for acute GR or does it occur under all conditions? Are Snf1 and other core autophagy components recruited to the vacuole in an Atg14 dependent manner?

The authors convincingly show that Snf1 activity is required for lipophagy and longevity during acute GR, but is it sufficient? The authors should test whether yeast mutants that show constitutive Snf1 activity (deletion of *reg1* or equivalent strains) render cells long lived during gradual GR.

The authors need to include a wild type control [Figure 6E](#fig6){ref-type="fig"}.

*Reviewer \#2:*

The authors investigate the mechanisms underlying lipid metabolism during starvation in budding yeast. Specifically, they examine the effects of acute versus gradual glucose restriction and describe differences between these two starvation conditions. Amongst the differences, they focus on lipophagy, which specifically occurs under acute glucose starvation conditions. Their characterizations suggest that AMPK is the selective upstream regulator of Atg14-dependent lipophagy, as opposed to bulk autophagy, under acute glucose restriction. More preliminary localization data suggest that Atg14 is recruited to the vacuole at ergosterol rich domains in an AMPK dependent manner where it functions to recruit lipid droplets for turnover.

The results shown in [Figure 1](#fig1){ref-type="fig"} are descriptive and are not integrated with the rest of the manuscript.

Is gradual glucose starvation the same as growing the cells to stationary phase?

The observation that rapamycin treatment blocks lipophagy during glucose starvation is contrary to what has been previously observed. It has been reported that TORC1 is inhibited when cells are starved for glucose based on assays using Sch9 phosphorylation. In addition, *snf1* deletion slows, but doesn\'t block the decrease in TORC1-dependent Sch9 phosphorylation in response to glucose starvation ([Figure 5A](#fig5){ref-type="fig"}<http://www.genetics.org/content/198/2/773>). The work would benefit from a more detailed characterization of the apparent antagonizing roles of AMPK and TORC1 in regulating differences between nutrient sensing (amino acids vs carbon source starvation) and types of autophagy.

What is the mechanism for Atg14-dependent lipophagy? The authors state \"Once vacuole-associated, Atg14p and other autophagy factors (including Atg6p) create sites on the vacuole surface where LDs can bind and internalize by an autophagic process.\" What exactly is this process? The authors speculate that is a form of microautophagy. In this context, the conclusion that Atg14 localizes to egosterol enriched vacuolar domains is not sufficiently supported by data presented in [Figure 7](#fig7){ref-type="fig"}. Without a functional context, these data are too preliminary. The manuscript would be improved by focusing on the mechanism of lipophagy.
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Author response

*Essential revisions:*

*1) The events post Atg14 association to the vacuole in the clearance of lipid droplet are not clear. The data that Atg14 localizes to ergosterol enriched domains is not convincing ([Figure 7](#fig7){ref-type="fig"}). What other components are recruited to the ergestorol enriched vacuolar domains? The details are clearly outlined by the reviewers in the section reporting complete reviewers\' criticisms.*

To further characterize the events post-Atg14p association to the vacuole, we a) provide more convincing data that Atg14p localizes to ergosterol-enriched domains (which we now refer to as L~o~ vacuole domains), b) demonstrate what other components are recruited to these L~o~ domains, and c) address other concerns related to this topic raised by the reviewers.

A\) To provide more convincing data that Atg14 localizes to L~o~ domains, we imaged Atg14-GFP expressing cells undergoing acute GR by AIRY-scan superresolution microscopy and analyzed the data using a 3D volume rendering method (Imaris). With the improved spatial resolution and 3D renderings of Atg14p and Vph1p (or Pho8p) (i.e., liquid-disordered membrane (L~d~) domain markers (Toulmay and Prinz, 2013)), we confirmed that Atg14p localizes to L~o~ domains on the vacuolar membrane. We further showed that LDs, labeled using Erg6-DsRed, localize exclusively in large L~o~ vacuole membrane domains prior to being internalized into the vacuole in cells undergoing acute GR ([Figure 8A](#fig8){ref-type="fig"}). This suggests L~o~ domains serve as preferential sites for LD uptake into the vacuole. By contrast, in cells undergoing gradual GR, in which Atg14p localizes to ERES instead of the vacuole membrane, L~o~ domains on the vacuole were much less apparent and LDs remained cytoplasmic, with none taken up into the vacuole ([Figure 8B](#fig8){ref-type="fig"}).

We also used AIRY-scan confocal microscopy to examine the vacuolar localizations of Atg14p, Atg6p and a vacuole L~d~ domain marker under acute GR. 3D volume reconstruction and maximum projection images revealed Atg14p molecules localizing as punctate elements within vacuolar L~o~ domains ([Video 3](#media3){ref-type="other"} and [Figure 8C](#fig8){ref-type="fig"}). Single z-slices from these images showed Atg14p was preferentially localized on the edges of L~o~ domains ([Figure 8C](#fig8){ref-type="fig"}, Single z-slice), in close association with LDs ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Atg6p was also localized in L~o~ domains at the vacuole surface but was more broadly distributed relative to Atg14p ([Figure 8D](#fig8){ref-type="fig"}).

To address whether Atg14p and/or Atg6p are critical for creating the large L~o~ domains on vacuole membranes under acute GR, we deleted the gene for each protein and then examined whether or not L~o~ domains were formed. Little or no L~o~ domains were observed in either *atg14△* or *atg6△* cells under acute or gradual GR, with the effect most potent in *atg6△* cells ([Figure 8E and F](#fig8){ref-type="fig"}). Given Atg6p resides on the vacuole membrane irrespective of the starvation condition (see [Figure 7C](#fig7){ref-type="fig"}), whereas Atg14p redistributes to the vacuole membrane in response to acute GR ([Figure 6A and B](#fig6){ref-type="fig"}), the results suggested Atg14p helps drive large-scale L~o~ formation under acute GR, with a critical supportive role played by Atg6p. Consistent with this, fewer large-scale L~o~ domains formed in *snf1△* cells under acute GR ([Figure 8E and F](#fig8){ref-type="fig"}), a condition where Atg6p resides on the vacuole surface but Atg14p fails to be recruited (see [Figure 6D](#fig6){ref-type="fig"}).

B\) To demonstrate what other components are recruited to the vacuole under acute GR, we monitored the distribution of GFP-tagged Atg6p, Atg38p, Vps15p, Vps34p, and Vps38p, which are autophagy-related, PI3K complex I components. Vacuole association of each PI3K complex I component was scored by AIRY-scan confocal microscopy image analysis. Prior to glucose starvation, Atg6p and Vps15p both showed significant association with the vacuole surface. Atg6p remained localized to the vacuole after shifting to either acute or gradual GR, but Vps15p redistributed off the vacuole upon acute GR ([Figure 7A and B](#fig7){ref-type="fig"}). The other PI3K complex I components (i.e., Atg38p, Vps34p, and Vps38p) remained primarily cytosolic with no increased vacuolar association upon shift to either acute or gradual GR ([Figure 7A and B](#fig7){ref-type="fig"}). Therefore, only Atg6p and Atg14p reside on the vacuole surface under acute GR. Atg6p remained prominently localized at the vacuolar surface even when AMPK was inactive (i.e., in *snf1Δ* cells or during gradual GR) ([Figure 7C](#fig7){ref-type="fig"}), whereas Atg14p was primarily ERES-associated under these conditions ([Figure 6A and D](#fig6){ref-type="fig"}). Therefore, only Atg14p's vacuolar localization was AMPK-dependent.

*2) Is the effect of lipophagy on cell survival direct? The reviewers have suggested experiments that could potentially help address this concern. What is the effect of deletion of regulators of Snf1 on cell survival? The details are clearly outlined by the reviewers in the section reporting complete reviewers\' criticisms.*

We provide additional data, including experiments suggested by the reviewers, that now strongly suggests that µ-lipophagy has a direct role in cell survival under starvation. First, when we prevent LDs from forming in cells by knocking out key LD biosynthetic enzymes (i.e., LDΔ, SEΔ, and TAGΔ cells), cell viability under starvation drops significantly ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Since LDs are absent and no µ-lipophagy occurs in these cells, the results support the idea that µ-lipophagy's downstream effects (i.e., LD consumption to drive OXPHOS) are essential for cell survival under glucose starvation. Second, removal of Atg14p, the protein we propose helps direct µ-lipophagy, prevents µ-lipophagy without blocking general autophagy, and reduces overall cell viability under acute GR ([Figure 5G](#fig5){ref-type="fig"}). Third, different conditions that prevented Atg14p from relocating from ERES onto the vacuole (where Atg14p functions in µ-lipophagy) caused reduced cell survival under acute GR. These conditions included: knock-out of AMPK (s*nf1△* cells); inactivation of TOR through rapamycin-treatment; and inactivation of TOR through amino acid removal. Fourth, µ-lipophagy and long-term survival still occurred in mitophagy-deficient (e.g., *atg32Δ* and *atg33Δ*) cells or pexophagy-deficient *atg11Δ* cells undergoing acute GR ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), indicating that µ-lipophagy is more significant than either mitophagy or pexophagy for cell longevity under starvation by acute GR conditions.

*Complete reviewer comments:*

*Reviewer \#1:*

*\[...\] 1) What is the relative contribution of sustained general autophagy and selective lipophagy for cell survival?*

Our data suggest that both general autophagy and µ-lipophagy are critical for long-term survival under nutrient starvation. When either pathway is compromised or inhibited, long-term survival under starvation is lost. For example, we observed µ-lipophagy is absent and general autophagy is present in both *atg14Δ* cells and cells starved by rapamycin-treatment or gradual GR; and these cells failed to live long-term. We further found that blocking autophagy by knocking out genes for core autophagy machinery (e.g., Atg1p and Atg5p) significantly reduced long-term cell viability under acute GR.

As mentioned above, a major point of our study is that cells switch on both µ-lipophagy and bulk autophagy pathways under acute GR to allow selective recycling of LDs (via µ-lipophagy) as an alternative energy source and recycling of proteins (via bulk autophagy) as a nitrogen source. Mitophagy or pexophagy were not needed since blocking either of these pathways by deleting *ATG11* or *ATG32*, respectively, did not decrease long-term cell survival under acute GR ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3C](#fig5s3){ref-type="fig"}).

*The authors provide evidence indicating that conditions inducing lipophagy are correlated with longevity during acute GR. This conclusion depends mainly on the phenotypes associated with deletion of Snf1 or Atg14. However, it is important to note that the deletion of atg14 strongly compromises non-selective turnover of a cytosolic model substrate (GFP-Pho8d60) after two days of acute GR raising the possibility that general autophagy defects contribute to or cause shortened lifespan of this mutant.*

We agree that general autophagy defects may contribute to the shortened lifespan of the *Atg14△*cells, but we believe a major defect is from blockade of µ-lipophagy. This is based on our observation that other conditions in which cells are unable to switch on µ-lipophagy (e.g., rapamycin-treatment or gradual GR) result in cells having shortened lifespans. Without µ-lipophagy-mediated LD catabolism, therefore, general autophagy alone is not sufficient to enable long-term cell survival under prolonged glucose starvation. We speculate that one of µ-lipophagy's downstream roles is to provide energy for sustaining general autophagy or other selective autophagy pathways under long-term starvation. Further studies are needed to test this possibility.

*In addition, AMPK/Snf1 deletion compromises the regulation of a number of cellular functions other than lipophagy including fatty acid synthesis, mitochondrial activity, and b-oxidation of fatty acids, which likely contribute to the shortened phenotype observed for this mutant.*

We agree that these other processes likely contribute to the shortened phenotype observed for the *snf1△* cells.

*First, to strengthen the postulated role for lipophagy in lifespan regulation, the authors should measure wild type cell survival in SC media in the presence or absence of rapamycin during gradual and acute GR. As shown in [Figure 3C and D](#fig3){ref-type="fig"}, addition of rapamycin does not affect the general autophagy response judged by GFP-Atg8 turnover, but selectively reduces lipophagy (Erg6-DsRed turnover) to rates observed for gradual GR. Thus, if lipophagy plays a central role under these conditions, one would expect a dramatically shortened lifespan upon addition of rapamycin during acute GR.*

We performed this experiment and found a dramatically shortened lifespan upon addition of rapamycin to cells undergoing acute GR (see [Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). As rapamycin treatment reduces µ-lipophagy, this result supports the thesis that µ-lipophagy plays an important role in the regulation of cell survival during glucose depletion. We further measured the lifespans of cells undergoing gradual or acute GR under different amino acid starvation conditions (i.e., SD versus SC). Similar to rapamycin-treatment, amino acid depletion dramatically shortened the lifespans of these cells ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). These new data are now included in the revised manuscript.

*Second, the authors show that deletion of atg14 decreases cell survival during acute GR, but do not formally demonstrate that defects in other core autophagy components (atg1, atg5, atg23) reduce lifespan.*

To address this comment, we have included new data showing that cells lacking *ATG1, ATG5* or *ATG23* genes all have reduced lifespans under acute GR. This is shown in [Figure 5---figure supplement 3A](#fig5s3){ref-type="fig"}.

*Third, the authors should test whether lipid droplets are required for long chronological lifespan by testing cells that are defective in the biogenesis of lipid droplets.*

We have tested this and now show that cells defective in LD biogenesis do not survive long-term during glucose starvation. This is in agreement with prior work of (Velázquez et al., 2016) highlighting the LD's critical role in cell survival. We have included this data in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}.

*2) The lipophagy-specific function of Atg14 is unexpected and intriguing. However, in which capacity Atg14 functions in lipophagy remains underdeveloped, since the authors included only Atg6 in their analysis. The authors should analyse the remaining components of the PI3 kinase complexes including Vps34, Vps15, Vps38, and Atg38.*

We performed these experiments in cells expressing GFP-tagged versions of the remaining PI3 kinase complex components. Vps34p, Vps38p, and Atg38p were distributed in the cytoplasm and Atg6p localized on the vacuole whether or not cells were starved. Vps15p, however, redistributed off the vacuole upon acute GR. These results suggest Atg14p's regulation of µ-lipophagy on the vacuole surface likely requires only Atg6p among the complex components.

*The physical interaction between Atg14 and Snf1 is interesting, but its significance is unclear. Is this interaction specific for acute GR or does it occur under all conditions?*

We found that the Atg14p-Snf1p interaction was not significantly altered by different GR conditions in our IP experiment. This suggests that Snf1p phosphorylation is not required for Atg14p and Snf1p to interact. It is possible, therefore, that some type of posttranslational modification of Atg14p occurs in response to AMPK activation and that this modification is what determines Atg14p's involvement in µ-lipophagy. This possibility and others are now being investigated.

*Are Snf1 and other core autophagy components recruited to the vacuole in an Atg14 dependent manner?*

To address this comment, we imaged Snf1p (not shown) and other core autophagy factors (including GFP-tagged Atg6p, Atg38p, Vps15p, Vps34p, and Vps38p) in cells undergoing acute GR, in which Atg14p relocates onto the vacuole. None of these components were recruited onto the vacuole under these conditions. Indeed, Vps15p redistributed off the vacuole, while Atg6p remained vacuole-associated whether or not Atg14p was present there.

*The authors convincingly show that Snf1 activity is required for lipophagy and longevity during acute GR, but is it sufficient? The authors should test whether yeast mutants that show constitutive Snf1 activity (deletion of reg1 or equivalent strains) render cells long lived during gradual GR.*

Previous work has shown that cells lacking*REG1* enhance their respiration by activating yeast AMPK, resulting in increased viability over the course of 3 days (Bonawitz et al., 2007). However, when we conducted our longevity assay under gradual GR conditions in the presence and absence of excessive amino acids (i.e., SC gradual GR and SD gradual GR, respectively), loss of *REG1* did not increase cell longevity in the above conditions. Thus, although constitutive Snf1p activity helps delay loss of cell viability over the short-term, this activity may not be sufficient to drive all necessary long-term survival programs. We have included the above data in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}.

*The authors need to include a wild type control [Figure 6E](#fig6){ref-type="fig"}.*

We have now included the wildtype data in [Figure 6---figure supplement 3A](#fig6s3){ref-type="fig"}.

*Reviewer \#2:*

*\[...\] The results shown in [Figure 1](#fig1){ref-type="fig"} are descriptive and are not integrated with the rest of the manuscript.*

In response to this comment, we have moved data examining the effects on stress resistance and mitochondrial morphology under acute versus gradual GR to [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. [Figure 1](#fig1){ref-type="fig"} now shows cell viability, respiration levels, and the localization of LDs under acute versus gradual GR. This sets up the physiological basis of our model system and is important for integrating conceptually and experimentally other data in our paper. We've added a 3D-rendered segmented organelle image to [Figure 1D](#fig1){ref-type="fig"} (bottom panels), as well as two supplementary videos ([Videos 1](#media1){ref-type="other"} and [2](#media2){ref-type="other"}), to highlight the different LD-vacuole organizations under gradual versus acute GR conditions. To the best of our knowledge, the SXT data in [Figure 1](#fig1){ref-type="fig"} provides the most detailed information of overall subcellular organization of LDs and the vacuole ([Videos 1](#media1){ref-type="other"} and [2](#media2){ref-type="other"}) in the yeast autophagy field.

*Is gradual glucose starvation the same as growing the cells to stationary phase?*

Yes.

*The observation that rapamycin treatment blocks lipophagy during glucose starvation is contrary to what has been previously observed.*

Several studies have reported that TOR inactivation by rapamycin or amino acid starvation triggers lipid droplet biogenesis and does not induce vacuolar LD delivery (Velázquez et al., 2016; Wang et al., 2014). These findings support our findings that TOR inactivation prevents LD degradation. The references that the reviewer refers to are not provided so it is difficult to explain any discrepancy. However, if there are any discrepancies, we are happy to investigate them in future work.

*It has been reported that TORC1 is inhibited when cells are starved for glucose based on assays using Sch9 phosphorylation. In addition, snf1 deletion slows, but doesn\'t block the decrease in TORC1-dependent Sch9 phosphorylation in response to glucose starvation ([Figure 5A](#fig5){ref-type="fig"}<http://www.genetics.org/content/198/2/773>). The work would benefit from a more detailed characterization of the apparent antagonizing roles of AMPK and TORC1 in regulating differences between nutrient sensing (amino acids vs carbon source starvation) and types of autophagy.*

We agree with the reviewer that a more detailed characterization of the antagonizing roles of AMPK and TOR would add to the paper. To address this, we now provide more detailed analysis and discussion on this topic. First, we found that AMPK cannot be activated under starvation conditions when TOR is inhibited beforehand (i.e., rapamycin treatment, gradual GR, or acute GR in rapamycin-treated cells). We speculate that this arises because TOR inhibition induces bulk autophagy and causes a surplus of amino acids, raising ATP levels to antagonize AMPK activity. Second, we demonstrate that rapamycin and gradual GR treatments (which each inhibit TOR) cause proteasomal degradation of AMPK. This relates to the finding that mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system (Zhao et al., 2015). Third, we show that addition of rapamycin to cells undergoing acute GR causes AMPK to be degraded and cell longevity to be shortened. We discuss this from the perspective of the role of µ-lipophagy in long-term survival under starvation, and µ-lipophagy's requirement for AMPK activation. Indeed, the results help explain why treatments that inhibit AMPK activation, despite triggering TOR inactivation and bulk autophagy pathways, are insufficient for promoting long-term cell survival. Overall, our data suggest that the antagonism between AMPK activity and TOR inhibition allows cells to engage in different types of autophagy to suit their metabolic demands under different starvation conditions. Therefore, cells starved of amino acids prior to glucose removal (i.e., gradual GR or rapamycin-treatment) switch on only bulk autophagy pathways to recycle nitrogen sources. In cells starved acutely of glucose before amino acid withdrawal (i.e., acute GR), by contrast, both µ-lipophagy and general autophagy pathways are switched on. Consequently, these cells are able to survive long-term due to LDs being used as an alternative energy source.

*What is the mechanism for Atg14-dependent lipophagy? The authors state \"Once vacuole-associated, Atg14p and other autophagy factors (including Atg6p) create sites on the vacuole surface where LDs can bind and internalize by an autophagic process.\" What exactly is this process? The authors speculate that is a form of microautophagy. In this context, the conclusion that Atg14 localizes to egosterol enriched vacuolar domains is not sufficiently supported by data presented in [Figure 7](#fig7){ref-type="fig"}. Without a functional context, these data are too preliminary. The manuscript would be improved by focusing on the mechanism of lipophagy.*

In the revised paper, we have made considerable effort at characterizing the mechanism(s) underlying µ-lipophagy, including further study of the roles of specific autophagy components, and more detailed imaging of LDs, Atg14p and Atg6p localizations on the vacuole. Prior studies have demonstrated that ergosterol is a key factor required for generating liquid-ordered (L~o~) membrane domains on the vacuole surface (Toulmay and Prinz, 2013), and shown that Atg14p co-localizes with Ivy1p, a L~o~ domain marker on the vacuole (Wang et al., 2014). Using AIRY-scan super-resolution imaging combined with 3D volume rendering, we show more clearly that Atg14p localizes to L~o~ vacuolar domains and is excluded from liquid disordered (L~d~) membrane domains ([Figure 8C](#fig8){ref-type="fig"} and [Video 3](#media3){ref-type="other"}). We find Atg14p localizes on the edges of the L~o~ domains, whereas Atg6p is more broadly redistributed to the L~o~ domain ([Figure 8D](#fig8){ref-type="fig"}). We further show that L~o~ and L~d~ domains do not form in cells lacking either Atg6p or Atg14p, and that the domains are reduced in cells lacking Snf1p. From this and other data in our paper, we speculate that vacuolar-localized Atg14p helps differentiate L~o~ domains, perhaps by serving to link LDs to the vacuole surface, which would allow sterols from the LD to further drive phase partitioning on the vacuole surface. Once LDs are docked on L~o~ domains, the domains internalize with their associated LDs. These findings open up many new questions about µ-lipophagy that future studies should address.

[^1]: EUROSCARF, European *Saccharomyces cerevisiae* Archive for Functional Analysis, Institute for Molecular Biosciences, Johann Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.
